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Ovine IgG, IgM "nd IgA and antisera specific for these immunoglobulins
were prepared. These reagents were used to estimate immunoglobulin levels
in sheep sera and certain other body fluids including the respiratory
secretions. The results showed that a secretory IgA system existed in
the ovine respiratory tract. Furthermore IgA antibodies to Mycoplasma
ovipneumonia were identified in the lung fluid of a sheep clinically
affected with pulmonary adenomatosis.
IgA antibodies specific for Parainfluenza 3 were demonstrated in the
respiratory secretions of lambs which had been experimentally .infected
with the virus.
A large molecular weight non-immunoglobulin substance, which inhibited
Parainfluenza 3 and three other paramyxoviruses, was also identified in
the respiratory secretions of both conventionally reared and specific
pathogen free lambs. It is suggested that in certain reports non-specific
inhibitors present in the nasal secretions of calves may have been confused
with Parainfluenza 3 specific IgA antibody.
Attempts were made to define the protective role of nasal secretion
antibody with vaccination-challenge experiments in specific pathogen free
lambs. It was shown that live Parainfluenza 3 administered intranasally
stimulated comparable serum antibody titres but higher nasal secretion
titres than the same dose of live virus given intramuscularly. Inactivated
virus inoculated without adjuvant by either route stimulated low or undetect¬
able serum titres and no nasal antibody. Immunity to aerosol challenge,
as assessed by viral shedding from the nose and changes in post challenge
antibody titres, was best conferred by intranasal inoculation with live
virus. Hence there was some evidence that the presence of antibody in
the nasal secretions reduced the susceptibility to' infection.
In subsequent experiments it was found that intramuscular inoculation
of inactivated Parainfluenza 3 in complete Freund's adjuvant stimulated
high serum and nasal secretion titres, which protected against challenge.
However the nasal secretion antibody was IgG^, which was possibly select¬
ively transferred from serum. This contrasted with the earlier finding
of IgA antibodies in the respiratory secretions after intranasal inocul¬
ation of live virus and showed that a second mucous antibody system
existed in the ovine respiratory tract.
Results from an experiment with young colostrum fed lambs indicated
that maternal antibody alone could prevent infection with Parainfluenza 3
virus. This showed that the presence of cell-mediated immunity may not
be essential to prevent sheep becoming infected with this virus. In this
and a subsequent experiment it was demonstrated that colostral IgG passed
into the nasal and lachrymal secretions of young lambs. This finding
supported the earlier suggestion that IgG-^ is selectively transferred
from serum into the nasal secretions of young lambs. It is suggested
that the presence of maternal IgG^ antibodies in the respiratory secretions
of newborn suckled lambs could constitute an important defence mechanism
against respiratory infections before local antibody synthesis begins at
about two weeks of age.
SECTION I
INTRODUCTION
Sheep pneumonia was reported in 1959 as a world-wide disease of
considerable economic importance (Shirlaw, 1959)* More recent surveys
have confirmed this view. Crempien et al, (1973) cite the American
Sheep Producers Council who put the annual cost of ovine pneumonia in
the USA at 37 million dollars. In India pneumonia was estimated to
account for 15% of the mortality in one flock (Chattopadhyay et al,
1971)t whereas lung lesions were observed in 30% of 113 sheep examined
in another survey (Bhagwan and Singh, 1972). In Rumania 5«^% of 2708
sheep carcases had lung lesions, with a high incidence in young lambs
(Ungureanu et al, 1970).
Recent estimates of the cost of sheep pneumonia in the United
Kingdom are more difficult to obtain. During 1973 - 197^ 0.b% of
lungs obtained from *+93,090 sheep slaughtered in the Glasgow and
Edinburgh abattoirs were condemned (Sharp, personal communication).
Obviously this figure greatly underestimates the total number of animals
with lung lesions. A survey carried out between 1959 and 1961
showed that 10% of 715 deaths in sheep from 1^ farms were caused by
pneumonia (Hughes, 196^). Of probable equal or greater economic
significance is the production loss due to subclinical disease and to
non-fatal cases, although the cost of such loss is very difficult to
assess. In view of the trend towards more intensive husbandry of
sheep it is likely that the incidence of respiratory disease will
increase.
The aetiology of acute respiratory disease in sheep is not fully
understood. Various bacteria and mycoplasma have been incriminated,
but at the time this work began Parainfluenza type 3 (PI-j) was the
only virus which had been isolated from the respiratory tract of
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sheep affected with acute respiratory disease (Hore, 1966; Ditchfield,
1966; St. George, 1969; Sharp, 1973). Recently, however, Belak and
Palfi (197^) isolated Reovirus type 1 from lambs with pneumonia and
adenoviruses, which possibly have a role in acute respiratory
disease,, have been recovered from sheep faeces (McFerran et al, 1969;
McFerran et_al, 1971; Sharp et al, 197^+). Viruses have also been
isolated from maedi and pulmonary adenomatosis two chronic respiratory
diseases of sheep (Sigurdardottir and Thormar, 196^; MacKay, 1969 a & b)
and in the case of maedi the disease has been experimentally reproduced
with the virus (Gudnadottir and Palsson, 1967).
Although PI^ had been associated with field outbreaks of respiratory
disease and experimentally had produced pneumonia in lambs (Hore &
Stevenson, 1967), at the time this study began little information was
available on the immune response of sheep to the virus. This information
was considered essential if a prophylactic vaccine was to be developed.
When this investigation started considerable interest was being
paid to the role played by mucous antibody in preventing virus infections
of the human respiratory tract. Indeed, protection against parainfluenza
and rhinovirus infections in man had been reported to correlate more
closely with nasal secretion antibody than with serum antibody (Smith
et al, 1966; Perkins et al, 1969). However no information was available
on the existence and possible function of antibody in ovine respiratory
secretions. The main object of the work in this thesis was to determine
whether antibody did exist in the respiratory secretions of the sheep.
If so, the aim was to characterise this type of antibody and if
possible to determine its role against PI infection.
Review of the Literature
A complete review of the vast literature on the studies of local
immune mechanisms in the respiratory tract will not be attempted.
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Besides, recent comprehensive reviews covering aspects of this subject
are available (Heremans, 1968; Tomasi and Bienenstock, 1968; The
Secretory Immunologic System, 1969; Rossen et al, 1971; Airborne
Transmission and Airborne Infection, 1973; Murray, 1973). Therefore
only salient findings from the studies in man and laboratory animals
most relevant to the work in this thesis will be described. However
the literature available from studies in sheep and cattle will be
reviewed in greater detail, but reports published later than 1970 will
be discussed later with appropriate findings in this study. Emphasis
will be placed on reviewing the studies of immunity in the respiratory
tract, but where appropriate reports on the local immunity of other
tracts may be quoted.
The concept of local immunity and local immunisation is by no means
new. Following experiments before the First World War many thousands
of people in the 1920s were successfully immunised with oral vaccines
against cholera, typhoid and other bacterial dysentries (Besredka,
1930). Local immunity in the respiratory tract to Pneumoccocci
infection was demonstrated in rabbits by Walsh and Cannon in the late
1930s (Walsh and Cannon, 1936; Walsh and Cannon, 1938). During the
early 19^0s reasonable evidence was presented for neutralising antibody
to influenza virus in human nasal secretions (Francis, 19^1; Francis and
Brightman, 19^1). Earlier reports exist for viral inhibitors in
human nasal secretions but the inhibition was probably non-specific in
nature (Amoss and Taylor, 1917; Burnet et al, 1939). After extensive
studies on murine influenza in the early 1950s, Fazekas de St. Groth
and Donnelly (1950) concluded that resistance to infection correlated
with the antibody levels in bronchial washings and was independent of
serum antibody. However despite these and other investigations, little
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further interest was paid to the possible importance of local immune
mechanisms in the respiratory tract until about ten years ago.
Interest in local immunity was re-awakened by the discovery of
human IgA. Detected first in the serum (Heremans et al, 1959)» IgA
was shown to be the predominant immunoglobulin in most human secre¬
tions, where it was present as a larger, lis molecule, attached to
an additional antigenic component (Hanson, 1961; Tornasi and
Zigelbaum, 1963; Tomasi et al, 1965). This extra protein, now
termed the secretory component, is not present on 7S serum IgA but
occurs free in the secretions of newborn children and agammaglobulin-
aemic patients (Tomasi and Bienenstock, 1968).
Since IgA is the predominant immunoglobulin in the secretions
whereas IgG is the major serum immunoglobulin, it follows that IgA
is either synthesised locally in the mucosa or else it is selectively
transported from serum. A considerable body of evidence has been
accumulated by a variety of techniques to show that IgA in the
secretions is locally produced. Radiolabelled amino acids fed in
vitro to organ cultures of various glands or portions of gut have
resulted in the production of radiolabelled IgA in the medium
(Hurlimann and Zuber, 1968; Lav/ton et al, 1970). Radiolabelled IgA
injected intravenously into human volunteers has resulted in little
or no excretion of IgA into saliva or nasal secretions, suggesting
that secretory IgA is not derived from serum IgA (Tomasi et al, 1965;
Butler et al, 1967; Strober et al, 1970). Immunofluorescent invest¬
igations employing antisera specific for IgA have revealed that the
bulk of plasma cells in the submucosa of the respiratory and gastro¬
intestinal tracts contain IgA (Crabbe et al, 1965; Brandtzaeg et al,
1967; Tourville et al, 1969)• IgA antibody production on a mucous
surface is mainly confined to that portion of the tract which
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received the antigenic stimulus (Ogra and Karzon, 1969 a). This last
finding is evidence for a local stimulation - local production concept.
It is known that human IgA exists as a 7S monomer in the serum
whereas in most other species serum IgA is a 9S dimer (Heremans and
Vaerman, 1971). An additional polypeptide termed the J chain is
present on 11S IgA and 19S IgM but not on 7S IgA or IgG (Halpern
and Koshland, 1970; Mestecky et_al, 1971). This protein was
originally thought to function as a 'junction chain', connecting
single molecules of the 2 immunoglobulins to form the IgA dimer and
the IgM polymer. However this function has recently been criticised
by Eskland and Brandtzaeg .(197*0 who have suggested that J chain is
essential for the combination of IgM and IgA with secretory component.
Following detailed immunofluorescent studies the following
mechanism has recently been proposed for the selective secretion of
IgA and IgM into human secretions (Brandtzaeg, 197*+ a and b). IgA
dimers and IgM polymers are produced by plasma cells in the submucosa
close to the epithelium. Serous type epithelial cells manufacture
free secretory component which is distributed in the cytoplasm and on
the membranes of these cells. Only immunoglobulins with the J chain
(i.e. IgA and IgM ) attach to the secretory component on the epithelial
cells and are secreted into the gland lumen. IgA predominates over
IgM in the secretions because of the relative abundance of IgA pro¬
ducing plasma cells in the submucosa. In addition, according to
Brandtzaeg (197*+ b), IgM does not bind as avidly to secretory
component as IgA.
Soon after the discovery of IgA, the anti-viral activity in human
nasal secretions was associated with this type of immunoglobulin.
(Artenstein et al, 1964; Bellanti et al, 1965). Since then numerous
studies have been carried out in man comparing the antibody response
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in the respiratory secretions and serum following vaccination by
either the respiratory or parenteral routes. Thus antibody activity,
usually shown to be due to IgA, has been demonstrated in the nasal
secretions following natural infection or vaccination with many viruses
including parainfluenza (Smith et al, 1966), influenza (Mann et al,
1968), rhino (Douglas et al, 1967) and polio (Ogra and Karzon, 1969 b).
In general it has been shown that both live and inactivated
viral vaccines stimulate higher nasal secretion titres when administered
by the respiratory route (Kasel et al, 1969; Waldman et al, 1968;
Downie, 1973)• Intranasal vaccination with live virus results in
greater nasal secretion titres than inactivated virus administered by
the same route (Downie, 1973)• Furthermore it has been shown with
rhinovirus and parainfluenza virus type 1 that protection correlates
more closely with nasal antibody than with serum antibody (Cate et al,
1966; Perkins et al, 1969; Smith et al, 1966).
Locally produced IgG and IgA type antibody has been found in
broncho-alveolar washings obtained from volunteers immunised with an
aerosol influenza vaccine (Waldman et al, 1973)* After natural infection
or respiratory immunisation IgA antibody has also been demonstrated in
sputum, saliva and tears (Mann et al, 1968; Douglas et al, 1967; Waldman
et al, 1970 a). The local antibody response induced with inactivated
viral vaccines is largely confined to that gland or mucous surface on
which antigen is deposited. Thus intranasal (IN) vaccination with
inactivated poliovirus stimulated antibody in the nasal secretions but
not in the gut (Ogra and Karzon, 1969 b). Ogra and Karzon (1969 a) also
immunised children who had double-barrelled colostomies with inactivated
poliovirus. The response to local immunisation of the distal colon
was limited to the distal segment. No antibody response was detected in
the serum, nasopharynx and the non-immunised proximal segment of the
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colon. Similar findings have been reported in the respiratory tract.
Vaccination with inactivated influenza virus by nose-drops resulted in
relatively high nasal antibody and low sputum titres, whereas vaccination
by an aerosol of small droplets stimulated high sputum and low nasal
secretion titres (Waldman etal, 1970 b).
It has been reported that IgA antibodies are "less specific" than
IgG. Nasal secretion IgA antibody cross neutralised closely related
strains of influenza virus, whereas serum IgG from the same individual
did not (Waldman et al, 1970 a). However secretory IgA may function as a
non-specific inhibitor because of its high sialic acid content (Alford
et al, 1967). Buscho et al (1972) reported that IgA did not cross
neutralise closely related strains of rhinovirus and suggested the effect
seen with influenza might reflect an unknown antigenic relationship of
the virus strains tested.
In man there appears to be little immunological memory in the
secretory IgA system (Smith et al, 1967; Ogra and Karzon, 1969 a;
Buscho et al, 1972). However studies in calves (Marshall and Frank,
1971)5 monkeys (Mattson et al, 197*0 and mice (Gerbrandy and van Dura,
1972) do show an anamnestic antibody response in the respiratory
secretions.
More recently cell mediated immunity has been reported in the
respiratory tract. By means of the macrophage migration inhibition
test, sensitised lymphocytes have been detected in lung washings
obtained from guinea pigs and men, immunised with a variety of antigens
including influenza virus (Henney and Waldman, 1970; Waldman et al,
1972; Jurgensen et al, 1973; Spencer et al, 197*0 • In these studies it
was found that alveolar washing lymphocytes were sensitised to a
greater extent if the antigen was administered by the respiratory
route. However splenic or circulating lymphocytes were more readily
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stimulated by parenteral immunisation. This suggests that a local cell
mediated response as well as a local antibody response follows
respiratory immunisation. An anamnestic alveolar and splenic cell
mediated response has recently been found in guinea pigs immunised
either IN or by footpad with influenza vaccine (Gadol et al, 197^).
The secondary response occurred in both alveolar and splenic
lymphocytes regardless of the route of the second dose of vaccine.
However both the primary and secondary response in the alveolar
lymphocytes was greater in the animals immunised by nose-drops.
However the role of cell mediated immune responses in the respir¬
atory tract to virus infections remains to be defined.
In ruminants secretion antibodies were first extensively studied
in the bovine reproductive tract with regard to vibriosis,
trichomoniasis and brucellosis (Pierce, 1959)• Antibody to these
organisms could be detected in the vaginal mucus often in the
absence of serum antibody (Florent, 19^7; Pierce, 19^6; Pierce, 19^7).
Thus it soon became apparent that a mucous antibody system which was
effective in vivo existed in the reproductive tract of the cow
(Pierce, 1950).
Although the first reports of attempts to measure antibody in
bovine nasal secretions do not appear until 1970 (Morein, 1970; Gates
et al, 1970; Goedmans, 1970; Duncan and Thompson, 1970; Provost, 1970),
earlier investigations had shown the efficacy of vaccinating calves IN
with attenuated strains of PI^ virus (Bogel and Liebelt, 1963 a).
Bogel and Liebelt (19^3 b) found that IN vaccination produced a serum
haemagglutination inhibition (HI) antibody response equal to that
stimulated by simultaneous IN and IM inoculations. However no serum
HI increase was observed following IN vaccination, if the calves had
very high maternal antibody titres and revaccination was essential
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6 months later.
Gates et al (1970) and Gutekunst et al (1969) found that calves
which had been vaccinated IN or naturally exposed to PI^, shed little
virus after experimental or natural challenge. However IM vaccinated
calves shed large amounts of virus after challenge and in one
experiment showed clinical signs of respiratory disease (Gutekunst
et al, 1969). It seemed therefore that the vaccine was more
effective when given IN and neither group of workers could correlate
serum antibody levels with protection. Gates et al (1970) attempted
to measure antibody in nasal washings but found anti-viral activity
to PI^ as well as PI^ and concluded that the effect was not due to
antibody.
Duncan and Thomson (1970) found antibodies to Pasturella
haemolytica in the nasal washings and sera of calves. Nasal washing
antibodies were detected consistently in calves exoosed to aerosols of
P. haemolytica whereas nasal antibody was not found in parenterally
immunised animals.
About this time the presence of IgA was firmly established in the
bovine (Vaerman et al,1969; Mach et al, 1969; Porter and Noakes, 197Q)•
In the secretions IgA was soon shown to be attached to secretory
component and to be the predominant immunoglobulin in most of these
fluids including the respiratory secretions (Morein, 1970; Mach and
Pahud, 1971; Watson and Lascelles, 1971). Fluorescent and in vitro
synthesis studies have further supported the concept of an IgA
mediated bovine secretory immune system, similar to that described in
man and other species (Mach and Pahud, 1971; Yurchak et al,1971;
Butler et al, 1972). However, except for one account describing PI^
specific IgA antibodies in the nasal secretions of calves (Morein,
1970), no reports were available before 1971 on the role of IgA in
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infectious diseases of the bovine.
Over the past decade considerable evidence has been presented
supporting the concept of an IgA mediated local immune system in the
sheep. Originally IgA was vaguely identified in sheep serum as a
precipitin arc on immunoelectrophoresis corresponding with the position
of IgA in human serum (Silverstein et al, 1963; Aaland et al, 1965, Pan
et al, 1968). However Vaerman et al (1969), using a cross reacting,
monospecific anti-human IgA serum, detected IgA in sheep serum. Since
then IgA has been isolated from sheep serum, colostrum and saliva and
monospecific antisera have been prepared for this immunoglobulin (Pahud
and Mach, 1970; Curtain and Anderson, 1971; Lascelles and McDowell, 1970).
In common with other species this immunoglobulin has been shown to be
attached to a secretory component in the secretions (Pahud and Mach,
1970), whereas in serum it exists largely as a 9S dimer as in the
bovine and goat (Mach and Pahud, 1971; Pahud and Mach, 1970). IgA
exists at low concentrations in sheep serum but is present in many
sheep body fluids (Watson and Lascelles, 1971; Pahud and Mach, 1970).
However before 19711 saliva was the only body fluid examined in which
IgA was shown to be the predominant immunoglobulin (Pahud and Mach,
1970). Fluorescent studies have shown that the plasma cells found near the
glandular epithelium of the mammary gland (antigenically stimulated) or
of the intestine are mainly of the IgA type (Lee and Lascelles, 1970;
Curtain and Anderson, 1971).
Evidence for local antibody production in the mammary gland of
the ewe has been reported by Lascelles and his collaborators. Comparing
normal glands and glands which had been infused with bacterial antigens,
these investigators found higher antibody titres in the whey milked
from the infused halves of each udder (Lascelles et al, 1966). In
addition the whey antibody titre was greater than the serum titre.
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Later the local antibody was shown to be distinct from IgG and IgM and
was eventually identified as IgA (Outteridge et al, 1968 a; McDowell and
Lascelles, 19^9; Lascelles and McDowell, 1970).
tu L
Antibody to helminth Oesophagostomum columban/um has been
e a
reported in intestinal mucus extracted from sheep infested with this
parasite. Antibody titres were higher in the mucus than the serum.
Moreover the highest mucous titres were present in those sections of gut
which contained most parasites, strongly suggesting that the mucous
antibody was of local origin (Dobson, 1966).
However despite these investigations there are few reports as to
the possible function of the local immune system in the sheep. In one
pertinent investigation Outteridge et al (1968 b) infused one side of l6
ewes' udders with a staphlococcal cell toxoid vaccine. Six weeks later
both glands were challenged with virulent organisms. Twelve non-infused




The first part of this section describes the techniques employed
in isolating sheep IgG, IgM and IgA and the preparation of antisera
specific for these immunoglobulin classes. In part 2 the methods
used for sampling various sheep body fluids are described and, using
the specific antisera prepared in part 1, results of the concentrations
of immunoglobulins estimated in each of these fluids are presented.
PART I
Preparation of Immunoglobulins and Specific Antisera
Introduction
Sheep IgG, IgM and IgA and antisera specific for these immuno¬
globulins were prepared using the techniques of salt precipitation and
ion exchange and gel filtration chromatography. These are commonly
used methods for the preparation of purified immunoglobulins and have
been employed by others who have prepared ovine immunoglobulins
(Pahud and Mach, 1970; Hudson et al, 1970; Reid et al, 1971).
Materials and Methods
Serum
About k 1. of blood were collected from the neck vessels of 3
sheep at slaughter. Pre-suckling blood samples were obtained from the
jugular vein of several newborn lambs. Blood samples were allowed to
clot and were left overnight at room temperature before the serum was
harvested. Serum was stored at -20°C.
Lung Fluid
Lung fluid was obtained from clinical cases of pulmonary
adenomatosis by elevating the affected sheep posteriorly and collecting
the fluid flowing from the nostrils. This fluid was filtered
(Whatman no. 1) and centrifuged (lOOOg, 10 minutes)to remove gross
debris before being stored at -20°C.
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Colostrum
This was collected by milking several ewes within 36 hours of
lambing. Colostrum was either stored at -20°C until used or the
whey was extracted within a few hours of milking.
Colostral Whey
Fat was first separated from the whole colostrum by centri-
fugation (lOOOg, 20 minutes). The lower aqueous layer (about 70% of
the total volume) was removed, warmed to 37°C and 2.5 ml of rennin
was added to each 100 ml. After about 2 hours incubation, the
resultant clot was broken up and following further centrifugation
(lOOOg, 20 minutes), the supernate was removed and stored at -20°C as
whey.
Preparation of gamma globulins
Gamma globulins were precipitated from whey or lung fluid by the
slow dropwise addition of saturated ammonium sulphate (SAS) to a
stirred volume of the fluid until the final mixture contained bo%
saturated SAS. The resulting cloudy solution was left to flocculate
for about one hour before centrifugation (l,500g, 10 minutes). The
precipitate was washed twice with bo% saturated SAS and redissolved
in a minimal volume of distilled water.
Ion Exchange Chromatography
This was carried out using either diethylaminoethyl (DEAE)
cellulose or DEAE Sephadex A 50. Acid washed cellulose was equilibrated
in 0.01M Na phosphate (P0^_) buffer pH 7.6 and packed in columns.
Columns were eluted stepwise at b°C using 0.01M P0^ pH 7.6 as the
starting buffer and the following Na CI concentrations in 0.01M
PO^ at pH 7.6 1) 0.01M 2) 0.03M 3) 0.05M k) 0.07M 5) 0.1M and 6)
0.2M. The sample applied to each column was equilibrated against the
starting buffer by dialysis or pressure dialysis. Individual column
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dimensions and flow rates are specified in the text. Details of the
methods used in preparing these buffers are described in Appendix 1.
DEAE Sephadex chromatography was carried out at room temperature
as described by Reid et al (1971) with the following modifications.
The Sephadex was equilibrated with 0.075M PO^, pH8 and subsequent
elution steps were performed using 0.2M PO^ and 0.2M PO^, 0.2M Na CI
buffers both at pH8.
Gel Filtration
This was carried out in columns with Sephadex G200 or Biogel A
1.5M.
Appropriate weights of Sephadex were swollen in buffer (0.1M Tris.
1M Na CI pH8 with 0.02% sodium azide), degassed and packed into
columns, the parameters of which are given at appropriate points in
the text.
Five hundred ml of Biogel were washed with several litres of
phosphate buffered saline pH 7^2 (PBS) and an appropriate volume
was packed in a 2.5 cm diameter glass column forming a bed length of
70 cm. This column was eluted at k°C with an upward flow of PBS at 12
ml per hour.
All column effluents were monitored at 25^nm with an LKB Uvicord
and fractions were collected by means of a fraction collector.
Preparation of Antisera
One ml of sheep serum or of an immunoglobulin preparation
(1-2 mg/ml) was injected intramuscularily (IM) with 1.0 ml of Freunds
complete adjuvant (FCA - 20% Falba in Bayol F with 10j*-g/ml freeze
dried mycobacteria) into New Zealand White rabbits. Three or k
inoculations were administered at 1*+-day intervals and thereafter
'booster' injections were given as necessary. The sera from several
bleeds from different rabbits were pooled and stored in aliquots at -20°C.
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Agar gel diffusion
This was carried out in a similar manner to Ouchterlony (1953).
Immunodiffusion was done with a variety of well patterns in 1%
Ionagar No. 2 in PBS, which had been layered in 10 rnl aliquots onto
glass plates (8x8 cm). The plates were held in humid boxes at
room temperature until the precipitin lines had formed. Slides that
were preserved were soaked overnight in PBS, washed with distilled
water and dried under damp filter paper at 37°C overnight. The dried
agar slides were fixed for 5 minutes in 2P/o aqueous acetic acid, stained
with 0.5% amido black in methanol/glacial acetic acid 9 : 1 for 7
minutes and decolourised with methanol/glacial acetic acid 9 : 1 for
15 minutes.
Immunoelectrophoresis (IEP)
A micromethod similar to that described by Scheideggar (1955) was
employed. Barbitone acetate buffer (0.05M Na Barbitone, 0.08M Na
Acetate pH 8.6) was used in the tank. Ten ml of 1% Ionagar No. 2 in
strength buffer was layered onto glass plates (8x8 cm). After the
agar had hardened, the samples were applied to small wells cut in the
agar and a potential difference of 100 volts was applied across the
slides for 1 hour. Troughs were then cut and the antisera applied.
Some slides were preserved as previously described.
Protein Determinations
These were kindly done by Mr. Dawson (Chemistry Department) by a
micro-Kjeldahl method, using the factor 6.25 for converting nitrogen
to protein.
Experimental Procedure
The procedure used in preparing each immunoglobulin and its
monospecific antiserum was as follows: first, rabbit antisera to pooled
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sheep serum were raised and used to detect the presence of IgG and IgM
I
by IEP analysis. Secondly, using colostral whey as the starting
material, an attempt was made to prepare crude IgM, IgG and IgA and
antisera to these fractions. Monospecific antisera to IgG and IgM were
produced by this method but no activity to IgA was detected. Sheep IgA
was detected with a monospecific, cross-reacting anti-bovine IgA serum
and so a monospecific serum to sheep IgA was eventually prepared. Thirdly,
these monospecific antisera were used in immunodiffusion tests to analyse
the immunoglobulins present in fractions from the chromatography columns.
Thus the standard preparations of IgG, IgM and IgA were obtained from
colostrum, serum and lung fluid respectively. In order to simplify
presentation, the preparation of each immunoglobulin and its specific
antiserum is described separately.
Results
Preparation of anti-IgG and IgG
Thirty ml of sheep colostral whey globulin were dialysed for 72
hours at b°C against several litres of 0.01M PO^ pH 7.6. This dialysis
resulted in a slight precipitate which was removed by centrifugation
(2,000g, 15 minutes) before the solution was applied to the DEAE
cellulose. Stepwise elution of the column as described in 'materials
and methods' resulted in a series of protein peaks exemplified in Fig I.
IEP analysis of the first b peaks with anti-whole sheep serum revealed
a single precipitin arc in the IgG^ position (Fig 2). Fractions
composing the first and second peaks were pooled and 1 ml aliquots
were inoculated into rabbits. The resulting antisera reacted with
sheep serum or whey producing a single line on gel diffusion and, on
IEP with serum, produced the characteristic lines with IgG^ and IgG,,
(Fig. 3A).
Two ml of the IgG preparation were filtered through Sephadex G200
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Fig. 2 Immunoelectrophoresis of IgG preparation.
Upper and lower,wells; IgG preparation.
Centre well; sheep serum.
Troughs; anti-whole sheep serum.
The anode is on the left.
Fig. 3 Immunoelectrophoretic analysis of specific antisera.
A upper well, sheep serum; lower well, sheep whey; trough, anti-IgG
B upper well, sheep serum; lower well, sheep whey; trough, anti-IgM
C wells, sheep whey; trough anti-IgA
D upper well, sheep serum (rich in IgA); lower well sheep whey;
trough, anti-IgA diluted l:k.
The anode is on the left.
(Column 90 x 2.5 cm, Flow 25 ml/hour) resulting in a single symmetrical
protein peak. This preparation was used as the IgG standard for the
single radial diffusion assay (Section II part 2).
Preparation of anti-IgM and IgM.
Anti-IgM Colostral whey globulin was filtered through Sephadex G200
(Column 70 x 2.5 cm, Flow l*f ml/hour) in 2 ml aliquots. Crude IgM was
obtained from the fractions contained in the leading edge of the
exclusion peak. The relevant fractions from several elutions were
pooled, concentrated in an ultrafiltration cell (Amicon filter XM 100),
and injected in 1 ml aliquots into 2 rabbits. When reacted immuno-
electrophoretically against sheep serum or whey, the antisera from these
animals produced several precipitin lines including dense arcs in the
characteristic IgG and IgM positions. A pool of antiserum was made
specific for IgM, as judged by gel diffusion and IEP analysis, after
absorption with IgG and precolostral lamb serum (Fig. JB). The anti¬
serum was first absorbed with O.k ml of precolostral serum per ml and
then anti-IgG activity was removed either by adding 0.28 mg IgG per ml or
by passing 2 ml aliquots of the serum through a column of IgG covalently
bound to sepharose beads (see below). Absorption reactions in
solution were left to react overnight at k°G or for 2 hours at 5V°C,
before the precipitate was removed by centrifugation (2,000g, 10
minutes).
IgM The euglobulins were precipitated from a 1.2 1 pool of sheep
o
serum by dialysis against running tap water for 5 days at 4 C. The
precipitate was dissolved in 18 ml 0.1M Tris - NaCl buffer, pH 8, and
filtered in 3 ml aliquots through Sephadex G200, (Column 90 x 2.5 cm,
Flow 25 ml/hour) at room temperature. A single protein peak with a
small trailing shoulder was produced by each sample at the exclusion
limit of the column (Fig. kk). Fractions forming the ascending
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Fig, k Preparation of IgM.
A Filtration of serum euglobulins through Sephadex G200.
Column: 90 x 2.5 cm. Flow rate: 25 ml/hour.
Sample: 3 ml. H = Fractions collected.
B Elution from DEAE Sephadex of IgM rich fractions pooled
and concentrated from 6 filtrations similar to A.
Column: 20 x 1.5 era. Flow rate: 20 ml/hour.
Fraction size: k.3 cm. Sample volume: 20 ml.
Starting buffer: 0.125 M PO^ pH8. Elution buffers:







Fig. 3 Immunoelectrophoresis of IgM preparation.
upper well; sheep serum,
lower well; IgM preparation,
upper trough; anti-whole sheep serum,
lower trough; anti-IgM serum.
(The anti-IgM serum was absorbed in solution with a
slight excess of IgG - hence the reaction between
the troughs).
The anode is on the left.
portions of the first peak were pooled, concentrated by pressure dialysis
against 0.125M PO^, pH 8, and applied to a column of DEAE Sephadex (20
x 1.5 cm; Flow 20 ml/hour) equilibrated against the same buffer. After
concentration the protein peaks eluted by the second and third buffers
each gave a single line corresponding to IgM on IEP analysis with anti-
sheep serum (Figs. and 5)• However on immunodiffusion a second faint
precipitin line was observed. This may have been due to slight contamin¬
ation with oC 2 macroglobulin, a protein which has similar physicochemical
properties to IgM, since later analysis with specific anti-IgG and anti-
IgA sera did not reveal any precipitin lines.
The partially purified IgM preparation eluted by the second buffer
was used as the IgM standard for single radial immunodiffusion and
contained 3.02 mg of protein per ml.
Preparation of anti-IgA and IgA
Aliquots of colostral whey were filtered through Sephadex G200 as
previously described. An attempt was made to raise crude anti-IgA serum
by immunising rabbits with fractions eluted just after the first protein
peak. These fractions had been reported to contain IgA (Pahud and Mach,
1970). Two rabbits were inoculated and bled over a b month period
However IEP analysis of their sera with whey revealed no activity which
could be ascribed to anti-IgA, although strong IgM and IgG precipitin
arcs were observed.
A pig antiserum, monospecific for bovine IgA and which cross-
reacted with sheep IgA was kindly supplied by Mr. T. Newby (Bristol
University Veterinary School). This antiserum, together with the
specific anti-IgG and anti-IgM sera, was used to monitor the
distribution of immunoglobulins when colostral whey globulin was
fractionated on DEAE cellulose, so that an IgA rich fraction could be
prepared. Preliminary experiments carried out on small columns
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(20 x 1.5 cms, Flow 50 ml/hour) with the buffer steps already described
showed that, while IgG was present in all peaks, IgA was not desorbed
until buffer 3 was applied while IgM was first eluted by buffer k (Fig. I).
This experiment was repeated several times on a larger scale (columns
20 x 2.5 cm; Flow 60 ml/hour). Fractions eluted by buffers 3 and ^ were
pooled, concentrated by pressure dialysis in PBS and filtered in 2 to k
ml aliquots through a column of Biogel A 1.5M (Fig. 6k). IgA was present
in the shoulder before the main peak, which contained the bulk of the
contaminating IgG. IgA rich fractions were pooled and after concentration
filtered through the same column, resulting in a single symmetrical peak,
the first half of which was pooled, concentrated and injected into rabbits
(Fig. 6B).
Antisera from these animals reacted with sheep whey on IEP analysis,
producing 2 main precipitin arcs in the IgG and IgA positions. A
fainter, faster migrating protein was also observed which appeared to
fuse at its cathodic extremity with the IgA arc (Fig. 3C). This line was
not detected when the antiserum was diluted l:*t in PBS, and it was
never detected with sheep serum (Fig. 3D). It was concluded that the
arc was probably the result of anti-secretory component activity reacting
with free secretory component in sheep whey. Specific anti-secretory
IgA serum was obtained after absorption with IgG and pre-suckling lamb
serum immunoadsorbents. On immunodiffusion with sheep and bovine whey,
this serum and the anti-bovine IgA serum produced identical precipitin
lines (Fig. 7).
Despite the chromatography procedures described, some 50/^ of the
protein in the IgA fraction prepared from whey was IgG. Later analysis
of some other ovine body fluids (Section II, part 2) revealed that
lung fluid from sheep with pulmonary adenomatosis contained no detect¬
able IgM and had a high IgA:IgG ratio. Since this fluid could also be
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Fig. 6 Partial separation of IgA by recycling through Biogel A 1.5 M.
Column: 70 x 2.5 cm. Flow rate: 12 ml/hour, | 1 Fractions
collected.
Elution A. Sample: IgA rich whey fraction eluted by
buffers 3 and k from DEAE cellulose.
Elution B. Sample: Fractions collected from 2 elutions
like A concentrated to 2 ml.
 
Fig. 7 Comparison of anti-ovine IgA and anti-bovine IgA sera.
1. anti-ovine IgA. 2. anti-bovine IgA. 3 & 5 ovine whey.
k. bovine whey.
obtained in large volumes it was considered likely to be better than
whey as a source for isolating IgA.
Therefore globulins, precipitated from 80 ml of lung fluid, were
dissolved in 10 ml distilled H20, dialysed in 0.01M PO^ pH 7.6 and
applied to DEAE cellulose (Column 20 x 1.5 cm; Flow 25 ml/hour)
equilibrated with this buffer (Fig. 8A). After the fall through peak,
buffers 3, 5? and 6 were applied and fractions in the last three
peaks, which contained IgA were pooled, concentrated and filtered
through Sephadex G200. A major peak containing IgA was eluted followed
by a smaller IgG shoulder (Fig. 8b). Fractions from the first half of
the IgA peak were pooled and concentrated to 2 ml by pressure dialysis
with PBS. On gel diffusion and IEP, this material gave a strong
precipitin line with anti-IgA identical to one produced by anti-whole
serum (Fig. 9). However a very faint line was also detected with anti-
IgG on immunodiffusion. This fraction contained 7*5 mg protein/ml and
was used as the IgA standard for the single radial diffusion assays.
Preparation of IgG and pre-suckling lamb serum immunoadsorbents.
The method of Porath et al (1967) as modified by Newby et al
(197^) was used to prepare IgG and pre-suckling lamb serum immuno¬
adsorbents, which were used for absorbing crude anti-IgA and anti-IgM
sera.
Fifteen ml of ice-cold Sepharose *+B was activated by the addition
of 10 ml of Cyanogen bromide (CN Br, 50 mg/ml) in a fume cupboard. The
pH of the reaction was maintained between 11 and 11.5 by the dropwise
addition of Na OH (1 - ION). After 2 to 3 hours, when the pH had
stabilised, the activated Sepharose was thoroughly washed with PBS and
packed in a small column (10 x 1 cms). Pre-suckling lamb serum diluted
1 : 10 in PBS or IgG (3 mg/ml) was recycled (20 ml/hour) through such
a column for 2 days at A°C by means of a pump. Unsaturated CN Br ions
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were quenched by pumping 0.1M ethanolamine, pH 8.5, through the column
for 1 hour and, after a further wash in PBS, the column was ready for
use. One to k ml of antiserum were applied and fractions forming the
fall-through peak were pooled. Antibody - antigen complexes were
dissociated by applying 10 ml of 6M urea, 0.2M glycine HC1 pH 2.2 to
the column and the resulting protein peak was discarded. After another
wash with PBS the column was ready for re-use.
Immunodiffusion tests with concentrated fall-through peaks showed
that the IgG column could absorb completely the anti-IgG activity of
up to 2 ml of either crude anti-IgA or anti-IgM serum, while the pre-
suckling lamb serum immunoadsorbent had a capacity of b mis for either
serum.
Both immunoadsorbents were used frequently over a period of about
9 months either at room temperature or at ^°C without any apparent
deterioration.
Discussion
It is not surprising that the IgG preparation consisted of the IgG^
subclass only, since it is well known that IgG^ greatly predominates over
IgG^ in sheep whey (Watson and Lascelles, 1975 a) • Hoivever, as
expected, antisera raised against this preparation reacted with IgG^
as well. No attempt was made to prepare antisera specific for each
subclass.
IgG^ in ruminants has a wide diversity of charge and can exist in
.polymeric form, properties which make complete separation of it from
IgA difficult (Pahud and Mach, 1970; Butler et al, 1972; Duncan et al,
1972). Therefore since colostrum contains such high concentrations of
IgG , it is not a suitable fluid from which to purify sheep IgA. Sheep
saliva and bovine tears and nasal secretions, fluids containing a high
IgA to IgG ratio with little IgM, have each been used as the starting
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Fig. 8 Preparation of IgA.
A Fractionation of lung fluid globulin on DEAE cellulose.
Column: 15 x 1.5 cm. Flow rate: 20 ml/hour. Sample: 15 ml.
Fraction size: 5 ml.
Buffers: 0.05, 0.07, 0.1 and 0.2 M NaCl all in 0.01 M
P0V PH 7.6.
B Filtration of IgA rich fractions through Sephadex G 200
Column: 90 x 2.5 cm. Flow rate: 25 ml/hour.
Sample: 2.5 ml concentrate of protein eluted in last 3













Fig. 9 Immunoelectrophoresis of IgA preparation.
upper well; sheep serum,
lower well; IgA preparation,
upoer trough; anti-whole sheep serum,
lower trough; anti-IgA serum.
The anode is on the left.
material in the preparation of IgA (Pahud and Mach, 1970; Morein, 1970;
Pedersen and Nansen, 1972). However these fluids are difficult to
obtain undiluted in large volumes. If clinical cases are available, it
seems that lung fluid from animals with pulmonary adenomatosis is a
very useful starting material for isolating sheep IgA.
The IgA and IgM preparations were not completely immunologically
pure. However the contaminants must have been present in very low
concentrations, since faint lines were only detected on gel diffusion,
despite total protein concentrations of 7*5 mg/ml and J>.0 mg/ml for the
IgA and IgM preparations respectively.
Some anti-secretory component activity was observed with the anti-
IgA serum. However this activity was low and double precipitin rings
were not observed in part 2 of this section, when samples were assayed
by single radial diffusion with this serum.
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PART 2
Immunoglobulins in Ovine Body Fluids.
Introduction
A review of the literature showed that IgG, IgM and IgA had been
detected in a number of sheep body fluids (Jonas, 1968 and 1969; Watson
and Lascelles, 1971)• However the concentrations of these immunoglobu¬
lins had only been reported for serum, colostrum, milk and saliva
(Pahud and Mach, 1970; Watson and Lascelles, 1973 a and b). As part of
this study on the immunity of sheep to PI^ virus, the immunoglobulin
concentrations in certain ovine respiratory secretions were estimated
using the specific antisera prepared in part 1. For comparison the
immunoglobulin content of serum, colostrum, milk, saliva, lachrymal fluid
and bile was also determined.
Materials and Methods.
Animals. Adult sheep of different breeds were sampled.
Serum was harvested from blood collected from the jugular vein.
Nasal secretions were collected by tampons in a manner similar to that
described for calves (McKercher et al, 1972). Small tampons+ (2.5 x 0.5
cm) were inserted into the ventral nasal meatus, withdrawn after 10 ■
minutes and squeezed out in a syringe yielding between 0.5 and 1.5 ml of
fluid. Tampons were carefully examined for the presence of blood and any
doubtful samples were tested by Haemastix*.
Tracheo-bronchial secretions were obtained from sheep lightly
anaesthetised with 0.25 ml Immobilon** given intravenously. An endo¬
tracheal tube was inserted, and a small piece of tampon attached to the
end of a polyethylene catheter was introduced as far as the carina.
+ 'Lil-lets', Southalls (Birmingham) Ltd.
* Ames Co., Miles Laboratories, Slough Bucks.
** Reckitt and Colman, Hull.
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Fig. 10 Single radial diffusion technique.
Agar contained anti-IgG serum diluted l:bO.
Standard solutions of IgG were placed in the wells in
the top row. All samples producing precipitin ring
diameters less than the most dilute IgG standard were
assayed again on plates using anti-IgG at 1:100 in
the agar.
After 1 minute the tampon was removed and expressed with 0.5 ml PBS in
a syringe. Anaesthesia was reversed with 0.25 ml of Revivon+ given
intravenously.
Lung fluid was obtained from clinical cases of pulmonary adenomatosis as
previously described.
Lachrymal fluid was obtained by placing a small pledge of tampon under
the lower eyelid for about 1 minute. The fluid (0.1 to 0.5 ml) was
squeezed from the tampon in a syringe.
Saliva was collected by holding small pieces of tampon under the tongue
for 1 to 2 minutes.
Bile samples, aspirated from the gall bladder shortly after slaughter,
were kindly supplied by Dr. Coop.
Colostrum was milked from ewes before suckling and milk was obtained 21
days after lambing.
Single Radial Diffusion Assay for Immunoglobulins.
The technique of Mancini et al, (1965) as modified by Fahey and
McKelvey (I965) was used to estimate IgG, IgA and IgM concentrations.
In preliminary experiments each monospecific .immunoglobulin anti¬
serum was incorporated into the agar in a range of dilutions in order to
find the highest dilution of serum which would still result in clearly
measurable precipitin rings. Thus molten 2?/o Ionagar No. 2 in 1% sodium
azide was mixed with an equal volume of antiserum diluted in buffer
(0.2M NaCl, 0.06M K^H P0^, pH 8) held at 56°C. Three ml of each agar
solution was poured onto a microscope slide and 5 equidistant 3 ram
diameter wells were cut in the agar when it had solidified. Using
capillary tubes, the wells were carefully filled to the brim with
dilutions of the appropriate standard solutions. Anti-IgG and anti-
IgA slides were left to react for 2b hours in humid boxes at room
+ Reckitt and Colman, Hull.
2:
temperature, whereas anti-IgM slides were incubated for hours.
Precipitin ring diameters were measured under dark background illumination
using a graduated viewer, held against the glass surface of the slide.
Results showed that the optimal dilution of each antiserum in
the agar was as follows: - anti-IgG 1/100, anti-IgA 1/60, anti-IgM V+0.
Anti-IgG serum was also used at 1/^+0 since high concentrations of this
immunoglobulin were present in some fluids. Routine estimations of
immunoglobulin concentrations were carried out under these conditions,
using 20 ml of agar on glass plates (9*9 cm) with 36 wells cut 1.2 cm
apart in the gel (Fig. 10). Six dilutions of a standard whey, a
standard serum or purified IgG were used in each anti-IgA, anti-IgM and
anti-IgG agar plate respectively. The ring diameters of the standard
dilutions were plotted against their respective concentrations on
semi-logarithmic graph paper. A straight line relationship was
obtained and the best line of fit was drawn after calculating the
regression coefficients. All samples were tested as neat except for
serum and colostrum. Serum was diluted 1/20 for IgG, whereas colostrum
was diluted 1/60 for IgG and 1/20 for IgA and IgM estimations. The
diluent used was PBS.
IgA and IgM concentrations were first expressed as a percentage
of the standard whey and standard serum. Later these standards were
calibrated to absolute IgA and IgM levels using the preparations
described in Part 1. The limits of detection were estimated as; IgG,
1.2 mg/100 ml; IgM 2.2 mg/100 ml and IgA 2.h mg/100 ml. Samples with
protein concentrations below these limits were arbitrarily assigned the
value zero.
Although the anti-IgA serum had weak anti-secretory component
activity (Section II, part 1), precipitin rings were never observed in
concentrated fractions in the 85,000 M.W. region when respiratory
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fluids were fractionated by gel filtration (Sections III and IV).
Therefore it was considered that the presence of free secretory
component in body fluids did not interfere with the IgA estimations.
Results.
1)Quantitation The mean concentrations of IgG, IgM or IgA in each
fluid examined are shown in Table 1. IgG, IgM and IgA levels were each
expressed as a percentage of the total immunoglobulin in an individual
sample. The mean percentages of all samples collected for each fluid
are presented in Table 2.
The predominant immunoglobulin in saliva, lung and lachrymal fluid,
tracheo-bronchial and nasal secretions was IgA and mean levels exceeded
those in serum where IgA was a minor immunoglobulin. Although high
levels of IgA were present in colostrum, IgA was a minor component of
the total immunoglobulin. IgA was detected at low levels in milk and
bile but represented some 10 and 20% of the total immunoglobulin
respectively. IgG was present in very high concentrations in colostrum
and serum and it was also the major immunoglobulin component in bile and
milk. Almost ^+0% of the immunoglobulin in nasal and tracheo-bronchial
secretions was IgG, whereas in saliva, lachrymal and lung fluids the
proportion was lower.
Although 10% of immunoglobulin in the serum was IgM, this immuno¬
globulin was never detected in lung fluid and was found in only a
single tracheo-bronchial sample. Low levels of IgM were also present
in some milk, saliva, lachrymal fluid and nasal secretion samples.
Although actual concentrations were low, IgM made up almost 20% of the
bile immunoglobulins - the highest proportion of IgM in all the fluids
examined.
2) Fractionation of serum and lung fluid immunoglobulins. Samples of



























































































































































pulmonary adenomatosis were filtered through Sephadex G200. The fractions
collected were first assayed for immunoglobulins and later each fraction
was tested by Mr. Jones for antibody to Mycoplasma ovipneumonia, a
common ovine respiratory mycoplasma. A sensitive indirect haemagglutin-
ation test was used and the initial titres in both serum and lung fluid
were greater than 1 in 4000. In the serum, IgM was eluted before IgG
which was -much.the predominant immunoglobulin, whereas IgA was not
detected in any fraction. Antibody activity was found exclusively in
fractions containing IgG (Fig. 11).
In the lung fluid, as expected, the major immunoglobulin was IgA,
which was eluted before IgG, while IgM was not detected in any fraction.
Although some antibody activity was found in fractions containing IgG
without IgA, the greatest titres were found in the tubes corresponding
to the peak concentration of IgA (Fig. 12).
Two mis of a serum sample which had a high IgA concentration were
filtered through Biogel A 1.5M. A protein trace with 2 peaks similar
to that shown in Fig. 28 (Section III, part 1) resulted. Eight ml
fractions were collected and individually assayed for IgA. IgA was
detected only in the fractions eluted between 170 and 230 mis with a
peak concentration occurring at about 200 ml. IgA was detected at the
same elution volume when whey (Section II, part 1) or nasal or tracheo¬
bronchial secretions (Section III, part 1) were filtered through the
same column under similar conditions.
Discussion
The concentrations of IgA and IgG in sheep serum approximate closely
the values reported by Pahud and Mach (1970), although these authors
found lower IgM levels to those reported here. However the IgM levels
in cattle sera reported by Mach and Pahud (1971) are also lower than
those given by other workers (Duncan et al, 1972; Pederson and Nansen,
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Fig. 11 Fractionation of serum from a sheep with pulmonary
adenomatosis by filtration through Sephadex G 200.
Column: 90 x 2.5 cm. Flow: 12 ml/hour. Fraction size: 10 ml.
Histogram shows antibodies to Mycoplasma ovipneumonia.
IgM IgG
Eluant Volume (ml)
Fig. 12 Fractionation of lung fluid by filtration through
Sephadex G 200.
Column: 90x 2.5 cm. Flow: 12 ml/hour. Fraction size: 10 ml.
Histogram shows antibody titres to Mycoplasma ovipneumonia.
IgA IgG
1972). A considerable variation was noted between sheep in the
concentration of immunoglobulins in samples of a particular body fluid,
but when concentrations were expressed as a percentage of the total
immunoglobulin, the variation was less. Similar variations are recorded
in values obtained for cattle, even when adjustment is made in relation
to the total protein content of the sample (Pedersen and Nansen, 1972),
and the data of Duncan and co-workers (1972) show considerable
variation from v/eek to week in samples taken from the same animal.
Later measurements (Section III, part 1) showed a similar situation in
sheep nasal secretions. When these factors together with variables
such as sampling technique and time after parturition are taken into
account, the values reported here for ovine saliva, milk and colostrum
are similar to the findings of others (Pahud and Mach, 1970;
Watson and Lascelles, 1973 a & b).
The immunoglobulin levels found here in sheep lachrymal fluid
are similar to results reported for the bovine (Pedersen and Nansen,
1972). In accord with the findings of Mach and Pahud (1971) in cattle
IgM constituted a relatively high proportion of bile immunoglobulins.
Sheep nasal secretions appeared to have a somewhat lower IgA to IgG
ratio than cattle (Duncan et al, 1972), although the possible effect of
a different sampling method was not ruled out. Tracheo-bronchial
secretions from normal sheep and lung fluid from sheep with pulmonary
adenomatosis had similar proportions of IgA and IgG with virtually no
detectable IgM.
The very high concentration of IgA in the lung fluid suggests
that most of the immunoglobulin is present in the fluid when it is in
situ in the bronchioles and alveoli and it is unlikely that the
flushing of the upper respiratory mucous surfaces by the lung fluid
during collection contributes significantly to the immunoglobulin
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content.
Gel filtration showed that serum IgA was larger than IgG and had
a similar molecular size to IgA in the secretions. Others have
estimated the molecular weight of sheep serum IgA at 350,000, which is
larger than IgG but smaller than secretory IgA (Pahud and Mach, 1970;
Beh et al, 197*0.
The results confirmed previous findings that IgA is the major
immunoglobulin in sheep saliva (Pahud and Mach, 1970; Vatson and Lascelles,
1973 b). A similar situation was found in lachrymal fluid and nasal
secretions. The much higher IgA to IgG ratio in these fluids compared
with serum proved that local production, selective transport, or a
combination of these mechanisms must operate for IgA at these mucous
surfaces. In addition, the finding that most of the lung fluid antibody
to mycoplasma was associated with IgA, suggested that IgA antibodies in





The immunoglobulin studies in Section II showed that an IgA system
was present in ovine respiratory secretions and that IgA antibodies to
at least one respiratory micro-organism could be detected in lung fluid
collected from cases of pulmonary adenomatosis. This section describes
experiments designed to study the immune response of lambs to PI
virus with particular reference to the characterisation and role of
antibody in the respiratory tract.
The first part of this section describes a study of the immune
response of 9 month old lambs following infection with PI . In addition
to antibody and immunoglobulin assays in the serum, nasal and tracheo¬
bronchial secretions, an attempt was made to detect cell mediated
immunity to the virus using an intradermal hypersensitivity test.
Three experiments carried out with specific pathogen free (SPF)
lambs are described in the second part of the section. In these
experiments the nasal and serum antibody response was measured after
single or combination inoculations of live or inactivated PI^>
administered either IN or IM. The protective effect of each type of-
•vaccination' was assessed by challenging the lambs with an aerosol of
live virus. The term 'vaccination' will be used throughout to include
primary exposure to live virus, although this was not attenuated in any
way. For ease of group to group comparisons the groups of lambs in the
3 separate experiments are numbered sequentially from 1 to 12.
Materials and Methods
Techniques common to this section and Section IV are mentioned here.
Other procedures and techniques relating only to a particular experiment
will be described with that experiment.
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Lambs. Nine month old conventionally reared Scottish Half Bred hoggs
were used in part 1 of this section. The animals were housed in the
isolation building, when it was not occupied by SPF lambs. The lambs
were fed commercial concentrates and hay ad lib. The groups were
housed in separate rooms, which as usual were pressure ventilated with
filtered air. Personnel attending the animals wore sterile clothing
and moved from the control to the infected group.
Hysterectomy derived, colostrum deprived lambs reared in conditions
sufficient to maintain their pathogen free status were used in the
experiments described in part 2 of this section (Hart et al, 1971)•
The animals were fed on sterilised diets of diluted condensed cows'
milk and chopped hay. Precautions were taken to reduce the risk of
cross contamination of virus between groups of lambs. Thus personnel
always moved from rooms containing control lambs to rooms containing
infected lambs and then to the outside of the isolation building. They
then showered and changed into fresh sterile clothing before re-entering
the animal rooms.
Erythrocytes. Guinea pig blood was collected by cardiac puncture and
stored in Alsever's solution at k°C. The erythrocytes were washed
three times in PBS and, after the packed cell volume had been
determined in a haematocrit tube, the cell suspension was adjusted to the
appropriate concentration with PBS. Chicken erythrocytes, from wing
vein blood, were prepared in a similar manner.
Tissue Cultures and Maintainance Medium. Monolayers of secondary foetal
lamb kidney cells (FLK) in tubes or Roux flasks were kindly supplied by
Miss Anderson and Mrs. Hood. The cells were maintained with medium
199 supplemented with 2?/o horse serum, 200 iu/ml penicillin and lOO^g/ml
streptomycin.
Virus. The G2 isolate of ovine PI (Hore, 1966) was used throughout
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these experiments at the sixth passage. The virus was propagated
on secondary FLK monolayers maintained with medium 199.
Preparation of Virus Pools. After removal of the growth medium, FLK
monolayers in Roux flasks were washed twice with Hank's basic salt
solution and incoulated with 2 ml of fluid containing the virus. The
virus was left to adsorb for 30 to 60 minutes at 37°C before 50 ml
of medium was added to each flask. After 5 or 6 days' incubation at
37°C, when a widespread cytopathic effect was observed, the flasks
were frozen and thawed twice to disrupt the cells and the culture
fluid harvested. Pools of infective fluid were centrifuged (1,500 g,
20 minutes) to remove the cellular debris and stored in aliquots at
-70°C until required.
Infectivity Titrations. Ten-fold serial dilutions of virus were made
by pipetting 0.2 ml of infective fluid in 1.8 ml PBS containing 1% bovine
serum albumin and 0.2 ml of each dilution was inoculated into each of
b to 6 FLK monolayers in tubes. Virus was left to adsorb for 1 hour at
37°C before.1 ml of maintenance medium was inoculated into each tube.
After A or 5 days' culture at 37°C, each tube was read by the haemadsorption
technique. The 50?o end point was calculated (Reed and Meunch, 1938)
and the infectivity was expressed as the number of tissue culture
infective doses per ml (TCID 50/ml).
Haemadsorption. This test was used to detect the presence of PI^ in
cell monolayers. Medium was removed from the tissue culture tubes and
1 ml of \°/a washed guinea pig red cells was added to each monolayer.
After about 30 minutes at room temperature, non-adherent red cells were
removed by 2 washes with PBS. The monolayers were then examined for
the presence of haemadsorption.
Virus inactivation. Pools of virus were inactivated with 0.2% formalin
{bOf/o formaldehyde solution) for 72 hours at 26°C. Inactivation was
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checked by inoculating 1.0 ml of this fluid into each of 15 FLK monolayers
in tubes. After 1 week, the supernate fluid from these tubes was
passed to further FLK cultures and 7 days later these were tested by
haemadsorption for the presence of virus. If no haemadsorption was
detected the virus was considered to have been inactivated.
Freund's complete adjuvant (FCA) was made up as described in Section II.
Virus Isolation. Nasal swabs were taken from the right nasal passage of
each lamb and were placed immediately into 3-0 ml of ice-cold transport
medium (Hank's balanced salt solution v/ith 2P/o bovine albumin, 600 .iu/ml
penicillin and 300 jj-g/ml streptmycin). Two-tenths of an ml of this fluid
was inoculated onto each of k FLK monolayers in tubes within 2 hours or
else the fluid was stored at -70°C until use. After 30 minutes at 37°C,
one ml of maintenance medium was added to each tube. The cultures
were read by haemadsorption after 6 or 7 days' incubation at 37°0.
Serum and nasal secretion samples. These were collected as described in
Section II part 2. It was found that tampons cut to approximately 0.5
cm x 0.5 cm were an appropriate size for lambs less than weeks old,
while 1.0 x 0.5 cm tampons were used in older animals. Nasal secretions
were collected from the left nostril (not the side swabbed for virus
isolation), examined for blood and stored as previously described for
adult sheep.
Immunoglobulin assays. IgA, IgG and IgM concentrations were estimated as
described in Section II, part 2. Most SPF lamb sera were tested undiluted
for IgG.
Virus Neutralisation Test. A microneutralisation test was employed
to allow large numbers of sera and secretions to be assayed for antibody
to PI-j* Similar tests have been used for detecting neutralising
antibody in the bovine (Hossi and Kiesel, 1971; McKercher et al, 1972).
One drop (0.025 ml) containing 16 TCID 50 (Range 8 - 32) of virus
was added to an equal volume of 2 fold dilutions of heat inactivated
(56°C for 30 minutes) serum or nasal secretions made in duplicate or
triplicate in flat-bottomed microplates.*' One drop (0.025 ml) of
medium was used as the diluent and the dilutions were made by means of
microdiluter* loops with 0.025 ml capacity. The medium used was
modified Eagle's minimal essential medium supplemented with 5% heat
inactivated foetal bovine serum, 1% 1.0M magnesium chloride, 200 iu/ml
penicillin, 100/u.g/ml streptomycin and 50 units/ml mycostatin.
Serum-virus mixtures were held at room temperature for 90 minutes
before approximately 1^,000 FLK cells in 0.1 ml medium were added to
each well. The plates were then sealed with tape to prevent 00^ loss
and incubated at 37°C. A confluent monolayer was obtained by ^8 hours.
On the fourth day of culture the seals were removed and 0.025 ml of 2%
guinea pig red cells was added to each well. After 30 minutes the
plates were washed with PBS to remove non-adherent red cells, excess
PBS was then removed and the plates were observed for haemadsorption.
Neutralisation was taken as occurring in those cups where no haemad¬
sorption was detected and neutralising titres were calculated by the'
method of Reed and Meunch (1938). Control positive and negative sera,
titrations of test virus and tests for the cytotoxicity of the samples
were included in each test. All titres in the text are expressed as
reciprocals.
At first some tests were done using U-bottomed microplates.
These plates have the advantage that the erythrocytes sediment to form
a button in the wells so that the end point of the test can be read
by haemagglutination. However it was found that reading the end point
by this method was more subjective.
*Cook Instruments, Flow Laboratories, Irvine, Ayrshire.
Haemagglutination (HA) and Haemagglutination inhibition (HI) Tests.
For PI^ Virus. A microtitre version of methods similar to those
employed by Hore (1968) were used.
Virus pools, prepared as described above, were used as the source
of haemagglutinin. HA activity was titrated in plastic microplates
with U-shaped wells using PBS as a diluent. Doubling dilutions of
virus were made with the diluters as described for the microneutral-
isation test, before 0.025 ml of a 0.5% suspension of guinea pig
erythrocytes was added to each cup. Plates were held for 1-J hours at
room temperature before the end points were read. The titre was taken
as the highest dilution of haemagglutinin to cause complete agglutin¬
ation of erythrocytes and this dilution was considered to contain one
HA unit per 0.025 ml.
All samples to be tested for HI antibody were inactivated at 56°C
for JO minutes. Aliquots of sera (0.2 ml) were diluted 1/10 in PBS and
absorbed with a 10$ suspension of guinea pig erythrocytes, to remove
any non-specific agglutinins. Due to the low antibody titres and
small volumes of sample available, various fractions and nasal secretion
samples were not absorbed with erythrocytes. Therefore control samples
without virus were always included in each test, but non-specific
agglutinins were never seen.
For antibody titrations serial 2-fold dilutions of each test serum
were mixed in microplates with equal volumes (0.025 ml) of a dilution
of virus containing k HA units. After 1 hour at room temperature,
0.025 ml of a 0.5% suspension of guinea pig erythrocytes was added to
each well. The plates were held at room temperature for 1-J to 2 hours
before the end point was read. For sera this was taken as the highest
dilution which completely inhibited HA, whereas for the nasal secretions
and fractions a 50% end point was used, in order to increase the
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sensitivity of the test.
Each test included a HA titration of the test virus and known
positive and negative serum titrations as well as erythrocyte controls.
For Newcastle Disease Virus (NDV). Formalinised (0.2%) NOV haemagglut-
inin (Hitchner B1 strain) was kindly supplied by Dr. S. McNulty (Royal
Dick Veterinary School, Edinburgh). An HI test was carried out using
k HA units in the way just described for PI except that a 1%
suspension of chicken erythrocytes was used. Since these cells
sedimented more rapidly than guinea pig erythrocytes the end point,
taken at 50% HA, could be read after 30 minutes.
For Parainfluenza tyoe 2 (PI_) virus. Human PI virus haernagglutininjj ^
was kindly supplied by Mr. Sharp. The virus had been passed 3 times in
Hep II cells after being supplied as a reference strain by the Central
Public Health Laboratory, London. Harvest material, diluted in PBS
to contain k HA units per 0.025 ml, was used in the HI test, which was
carried out using guinea pig red cells in the way described for PI^.
For Parainfluenza type 1 (PI^) virus. Sendai virus was obtained from
Mr. Scott. The virus had been propagated in eggs and was diluted in
PBS to contain k HA units per 0.025 ml. The HI test was carried out in
the manner described for
Treatment for non-specific inhibitors. Certain nasal secretion samples
and fractions were treated with receptor destroying enzyme (RDE)* in an
attempt to remove non-antibody inhibitors of HA. Three drops of RDE
were dispensed into each cup forming the top row of a U-bottomed micro-
titre plate and one drop (0.025 ml) of each sample under test was
added to these wells. The plate was sealed with tape and incubated over¬
night at 37°C, after which it was heated for 1 hour at 60°C in a
shallow water bath to destroy residual activity of the enzyme.
* Extracted from Vibrio cholerae , Lot K7892 Wellcome.
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The seal was then removed and doubling dilutions of each sample were
made in PBS using the microdilutors. Omitting the top row containing
the RDE, virus and erythrocytes were dispensed as before and the test
was read taking the dilution of the test sample in the second top row
at 1/8.
Fractionation of Serum and Nasal Secretions. Initial experiments
showed that a better separation of the 3 immunoglobulin classes was
achieved using filtration through Biogel A. 1.5M compared with Sephadex
G200, although G200 gave a better resolution of lower molecular weight
molecules (compare Figs. 19 and 28 with Figs. 11 and 12). Therefore
fractionation of serum and secretions was carried out by filtration
through an upward flowing column (70 x 2.5 cm) of Biogel A 1.5M in PBS
kept at + k°C. PBS was pumped through the column at 12 ml/hour and 8
to 12 ml fractions were collected. Neutralising and HI antibody
determinations were made on the fractions, usually after concentration
by dialysis in solid polyethylene glycol (20,000 MW). In order to
increase the sensitivity of the test, 50% inhibition of HA was read as
the end point in the HI assay. IgA, IgG and IgM were detected in the
fractions either by SRD or by double diffusion using the specific
antisera.
Aerosol apparatus and Challenge Procedures. The first apparatus built
for exposing lambs to aerosols is shown diagramatically in Fig. 13.
Aerosol, produced by a Wright nebuliser* operating at 10 pounds per
2
in from a compressed air cylinder, was directed into a 22 1. airtight
steel reservoir. Under these conditions about 0.1 ml of culture fluid
was nebulised each minute producing 8 1. of aerosol which, according to
the specifications of the atomiser, had a particle size less than 10yx
diameter. The aerosol cloud was withdrawn from the reservoir through a

















filter and flow meter by a vacuum pump adjusted so that the pressure
9
inside the chamber was atmospheric. After a few minutes, to allow
conditions inside the reservoir to stabilise, each lamb was restrained
in a sheep cradle and made to inhale for 10 minutes from a mask sealed
round its muzzle. The mask used was a small inhalation anaesthetic cone,
which had been extended by a 2 in. strip of polythene glued around the
rim of its wider opening. The polythene strip was held round the lamb's
muzzle with a strong elastic band to form a crude seal. The mask was
connected to the reservoir by a 2.5 cm diameter tube and a non-return
valve ensured that exhaled air passed to the atmosphere through a low
resistance filter. During the exposure period the flow through the
exhaust pump was reduced, by a rate considered equal to the lamb's
minute volume, so that the pressure in the reservoir remained atmos¬
pheric. A 5 minute sample of the aerosol cloud was obtained when a lamb
was not being challenged, by diverting the exhaust flow through an
impinger* containing 30-0 ml of transport medium with 0.1% anti-foaming
agent. An aliquot of the medium was titrated for virus infectivity and
hence, knowing the volume of aerosol passing into the fluid, the
infectivity of each litre of aerosol could be calculated. The dose of
virus (D) inhaled by each lamb was derived from the formula D = I x M x T,
where I is the infectivity per litre of aerosol, M is an estimate of
the lamb's minute volume in litres and T is the period of exposure in
minutes.
A preliminary trial of this apparatus was carried out in conjunction
with Dr. N. Gilmour. A 7 week old conventionally reared lamb was exposed
for 10 minutes to an aerosol of Pasturella haemolytica, nebulised from
9
a broth culture containing approximately 1.1 x 10 viable bacteria per
ml. An impinger sample was collected and 20 minutes later the lamb was
* All Glass Impinger. Millipore (U.K.) Ltd.
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killed and the lungs removed. One gm pieces from each lobe were ground
up with 5 ml of broth and dilutions of the lung suspension were
titrated and cultured overnight on blood agar plates. The number of
viable bacteria in each lung suspension sample ranged between 35 and
425 colony forming units/ml, while a total of 2 x 10^ viable cells were
estimated in the impinger fluid. These results indicated that P.
haemolytica remained viable in the aerosol and that large numbers of
viable particles were penetrating deep into the respiratory tract. In
4 3
another trial tissue culture fluid containing 10 TCID 50 PI^ per ml
l 8
was nebulised and 10 * TCID 50 was recovered in the impinger fluid,
showing that PI was also viable in the aerosol.
This apparatus was used for challenging the SPF lambs in
Experiment 1. An aliquot of the virus pool used for vaccination,
containing 10^ TCID 50/ml, was nebulised. The minute volume of the
lambs was estimated as 3 !• and, from the titre of the impinger fluid,
4.9
it was calculated that each lamb inhaled a total of 10 " TCID 50 of
virus.
This apparatus was used successfully in Experiment 1 and by others
in experiments with p. haemolytica and with adenovirus. However lambs
could only be exposed individually to the aerosol, a time consuming
procedure. Therefore, before Experiments 2 and 3j the apparatus was
modified so that 4 lambs could be exposed simultaneously (Figs, 14 and 15).
Eight l/minute of aerosol, produced as before, were mixed with 50
1 /minute of air from a compressor-vacuum pump and passed into a
0.3 exposure box with four 15 cm diameter holes. The relative
humidity of the mixing air could be increased above the ambient level
by controlling the proportion of it bubbling through a reservoir filled
with water. The humidity of the aerosol cloud was monitored by a
hygrometer in the exposure box. Each lamb's.head was passed through one
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.Fig. Ik Diagram of modified aerosol apparatus.
Key.
P = pump
FM = flow meter
MT = mixing tube
EB = exposure box
WR = water reservoir I = impinger
N = nebuliser F = filter




hole in the exposure box and restrained inside this chamber by a yoke
and a polythene sleeve, which was taped round the animal's neck to
form a seal. Aerosol leakage was further reduced by maintaining an
extraction rate of 80 1 /minute from the box. The four lambs in
each group were exposed simultaneously for 30 minutes. Ten minute
impinger samples were taken midway through certain exposure periods
in each experiment. In Experiment 2 tissue culture fluid containing
Q -j
10 * TCID 50 of virus/ml was nebulised and it was estimated from the
formula, assuming a minute volume of 3«1> that each lamb inhaled
1q5«3 tcid 50 Fluid containing 10^*° TCID 50/ml was
nebulised.in Experiment 3 but virus was not recovered in the impinger
sample, a finding which is discussed in the description of that
experiment.
Before and after use both sets of aerosol equipment were
disconnected and left to stand overnight in an atmosphere of formalde¬
hyde vapour, produced by adding formalin to potassium permanganate
crystals. In order to remove any traces of this gas, air was pumped
through the apparatus for 30 'minutes before the lambs were exposed.
Personnel operating the aerosol equipment always v/ore protective
respirators.
Necropsy Procedure. The lambs were shot with a humane killer and
exsanguinated by severing the vessels in the neck.
Histological Procedures. Blocks from representative areas of lung,
bronchus, trachea and nasal septum were fixed in 10$ formol saline
with secondary fixation in mercuric chloride. Fiveu. paraffin sections
were cut and, after processing, stained with celestin-blue haematoxylin
and eosin according to Culling (1963). Some sections were stained with
Pollack's trichrome (Pollack, 19M0 •
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PART I
Immunoglobulins, Antibodies and Inhibitors of Parainfluenza 3
Virus in the Respiratory Secretions of Sheep.
Introduction
The results from Section II indicated the presence of an IgA anti¬
body system in the sheep respiratory tract. The object of the
experiment about to be described was to determine whether IgA specific
antibody was produced in the respiratory secretions of lambs after
infection with PI^. Attempts were also made to discover if a delayed-
type hypersensitivity skin reaction could be elicited following
infection with this virus.
Experimental Procedures
Eight 9 month old Scottish Half Bred lambs, which were seroneg¬
ative for PI antibody were randomly placed into 2 groups of '+. The
animals were housed and fed as described in 'Materials and Methods'.
g
One ml of fluid containing 10 TCID 50 of PI_, was instilled into
5
each nostril of the lambs in one group. Lambs in the remaining, control
group each received the same volume of tissue culture fluid by the
same route. All lambs were swabbed daily for 1 week after inoculation
and clinical signs were noted during this period. Pre-inoculation blood
and nasal secretion samples were collected and thereafter at 2 to 5
day intervals for 5 weeks. Tracheo-bronchial secretions, obtained as
described in Section II, were collected from all sheep before
inoculation and '+,9, 18 and 23 days after inoculation. Samples of each
fluid were tested for HI and neutralising antibody to PI-,. The nasal
5
secretions were assayed for immunoglobulin content, and pools of nasal
and of tracheo-bronchial secretions were fractionated by gel filtration.
Virus Antigen. Virus from 60 ml of fluid identical to the inoculum was
pelleted by ultracentrifugation (5^,000 g, 2 hours). The pellet was
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resuspended in 2 ml of PBS and heat inactivated at 56°C for 10 minutes
(Hore, 1968). Control fluid from uninfected cultures maintained in
parallel was treated to all procedures in a similar way. The test
antigen contained 2560 HA units of virus/ml.
Intradermal test. An area about 6 inches square was clipped bare over
the lateral aspect of the thorax of each lamb and four smaller squares
were marked on the skin with a pen. Either 0.1 ml of antigen or 0.1 ml
of control fluid was injected intradermally within each delineated
square of skin. Thus each animal received 2 adjacent intradermal injections
of both virus antigen and control fluid. The skin thickness was
measured with calipers at each inoculation site before, and 2k, 48 and
72 hours after inoculation.
RESULTS
A muco-purulent nasal discharge, observed 3 to 6 days after
inoculation with virus, was the only clinical abnormality noted. This
sign was not observed in the control group. One of the control lambs
died on day 3 while anaesthetised for tracheo-bronchial secretion
sampling.
Virus was recovered on at least 2 occasions from nasal swabs taken
from each lamb in the infected group (Table 3) an^ was never recovered
from the control lambs.
HI antibody was first detected in the sera 7 to 9 days after the
lambs were inoculated with virus and neutralising titres v/ere found
about 2 days later (Fig. l6). Thereafter serum HI and neutralising
titres correlated closely except in lamb 882 in which an increase in
neutralising antibody, without a concomitant HI rise, was observed on
days 32 and 36. Antibody was never detected in the sera of the 3
surviving control lambs.











































































Fig. 16 Serum neutralising and HI titres in individual lambs
after infection with PI^.
Neutralising antibody.
—O HI antibody. o = -=-10I
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to 32. After RDE treatment the titres were reduced in 7 lambs to 8 and
activity was evident (Table b).
To check for the possibility of Hi activity in the tampon itself,
PBS)in which tampons had been immersed for 5 minutes and then expressed,
was tested and found to have no HI activity.
Pre-inoculation nasal secretion neutralising titres were less
than 2 and remained undetectable in the control lambs throughout the
experiment. In the infected group nasal secretion neutralising antibody
was detected by day 5 in 3 lambs, whereas in lamb 866 significant titres
were not recorded before day 18 (Fig. 17). Individual peak nasal
secretion titres ranged between 11 and 23. Nasal antibody persisted for
'4 weeks or more, although detection was sporadic towards the end of the
experiment.
Low neutralising titres were found in the tracheo-bronchial
secretions of 2 lambs 9 Hays after infection with no neutralising
activity detectable in the control or pre-inoculation samples. However
HI activity, at titres ranging from b to 16, was present in all the
samples.
The IgA, IgG and IgM concentrations found in control and infected
lambs' nasal secretions showed marked variation from day to day (Figs.
17 and 18). IgA predominated over IgG in all but 3 samples, in which
slightly higher IgG concentrations were recorded. Low levels of IgM
were present in most of the samples. No difference in nasal secretion
immunoglobulin levels was found between the control and infected lambs.
Fractionation of Secretions.
Nasal secretions from the lambs in each group, collected on days 11,
13 and 15 after inoculation, were pooled and fractionated by gel
filtration. After concentration, the HI titres and immunoglobulin levels
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Fig. 17 Immunoglobulin concentrations and neutralising antibody
titres in the nasal secretions of the infected lambs.
a o nasal secretion neutralising titre
O O serum neutralising titre
X*»< t«* <X IgA. in nasal secretions
a © IgG in nasal secretions
B o IgM in nasal secretions
Days after Inoculation
Fig.18Immunoglobulinconcentratio sitheasal secretionsofthcontrollambs. X•IgA —-0IgG ■aIgM
886
DaysfterInoculation
of each fraction were assayed. It was found that each pool of secretions
contained similar protein and immunoglobulin concentrations and that the
HI activity in the secretions from the control group was eluted as a
peak at the exclusion volume of the column (Fig. 19). HI activity was
found in this area in the nasal secretions from the infected group, but
activity was also present in the fractions containing IgA and no HI
activity was detected in the fractions containing IgG. The experiment
was repeated with a pool of secretions collected 18 to J>6 days after
inoculation and similar results were obtained.
Fractions from nasal secretions of the infected group were made into
3 pools termed A, B and C each containing only IgM, IgA and IgG
respectively (Fig. 19). After concentration each pool was tested for
HI activity to PI-^j P^g' ^3 an<^ Pool A inhibited the HA of all
k viruses, Pool B inhibited PI^ only and no activity was found in Pool
C (Table 5)• In. addition each pool was treated with RDE and the HI
activity to PI^ was retitrated. The titre of Pool B was not affected
by RDE, whereas a four-fold drop in activity was found in Pool A
(Table 6).
The post-inoculation tracheo-bronchial samples collected from the
infected lambs were pooled and fractionated. Two peaks of neutralising
activity were resolved (Fig. 20). The first was eluted in fractions near
the exclusion volume; IgM was not detected in these or any other fractions.
The second peak was eluted in association v/ith IgA, although several of
the later fractions in this peak also contained IgG. HI activity was
detected in the fractions containing neutralising activity, although the
HI activity was not resolved into 2 peaks so clearly. Substances with
high absorbance at 25*+ nm were eluted after IgG. These fractions were
not visibly coloured but tests showed that the absorbance could be
markedly reduced by dialysis against PBS.
Fig.19ractionationofnasalsecre i sfr minf teda dcontrol lambsbyfiltrationth oughBi gelA. . Column:70x2.5c .Fractionsize:1ml Samples:2lofnasalsecretionspooledandcon entrated fromsamplescollect dea hgroupbetwe n11and5 daysfterinoculation. Afterantibodytitr sndimmu oglobulinlev lshabe n estimated,fractionsotheinf ctedl mbw reado 3pools,termedA,BandC,sde icte .
......Infected □—□Control igG
Table 5.
HI activity In 3 nasal secretion fractions to PI,,,
PI„, PI, and NDV viruses.
d i ~
Fractions
Virus A B C
PI3 80 40 <2
PI2 8 <2 <2
NDV 8 <2 <2
PI (Sendai) 8 <2 <2
Table 6.
The effect of RDE on the HI activity of these fractions
to 'PI.,5-i
Fractions
Treatment* A B_ C,
RDE 20 40 <10
PBS 80 40 <10
* sample diluted l/5 with RDE or PBS
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Delayed hypersensitivity test. This was carried out 50 days after
inoculation. At this time 2 of the lambs which had been inoculated
with virus had serum HI titres greater than 10, whereas the remaining
lambs were seronegative for PI-j. Before intradermal inoculation, the
skin thickness of each lamb measured between 3 an<^ ^ mm• No
significant increase in thickness was detected at any inoculation
site on any lamb when the skin was measured 2k, 48 and 72 hours later.
Discussion
Inoculation of lambs with PI did not result in clinical illness,
a finding which has been reported previously (Hore, 1968; Gilmour et al,
I968). However isolation of the virus from nasal swabs taken from the
inoculated group provided evidence of infection of these lambs.
Most of the PI HI activity in the nasal secretions was considered
due to a non-antibody inhibitor. This large molecular \\reight substance
was found in pre-inoculation secretions and secretions from control
lambs. It was partially sensitive to RDE and inhibited the HA of PI^,
PI^ and NDV. However HI activity, specific for PI and insensitive to
RDE, was found in association with IgA in the nasal secretions of the
infected lambs only. This activity was therefore attributed to IgA
antibody. In individual nasal secretion samples IgA HI antibody could
not be detected and was probably masked by the non-specific inhibitors,
since no significant increase in HI titre was found after infection.
Therefore unless a simple method is found to specifically remove this
inhibitor, HI seems an unsuitable test for measuring ovine nasal
secretion antibody. The neutralisation test seems more appropriate
since rises in nasal secretion titre were found only in the infected
lambs. However after concentration, neutralising activity was detected
in the tracheo-bronchial secretions associated with a large molecular
weight substance presumed similar to the nasal secretion inhibitor.
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Since the tracheo-bronchial secretions contained no detectable IgM,
it seemed unlikely that any of the anti-viral effect noted in either
respiratoi-y secretion was due to specific IgM antibody. However, the
second peak of HI and neutralising activity in the tracheo-bronchial
secretions was considered largely due to IgA antibody. Some IgG antibody
may have been present in the tracheo-bronchial secretions but no HI
activity was found in the IgG fraction of the nasal secretions.
Nasal secretion antibody was usually detected before serum antibody,
which suggests that nasal antibody is independent from serum antibody.
Similar findings have been reported in calves (Morein, 1972). It was
not possible to associate the appearance of nasal antibody with
changes in the nasal secretion immunoglobulin concentrations since
marked day to day variations were found in both groups of lambs.
Immunoglobulin levels in bovine nasal secretions have also been shown
to vary considerably from week to week (Duncan et^al, 1972).
In the serum, HI antibody was detected before neutralising antibody
as noted by Hore (1968). Nasal secretion antibody did not persist as
long as serum antibody. Similar findings have been reported in calves
(Marshall and Frank, 1971), although in this species nasal antibody was
detected more than 17 weeks after infection as compared with the '4 to
5 week period found here. However, this may reflect differences in the
sensitivity of the neutralisation tests employed, or differences in the
dose of virus administered, since Marshall and Frank (1971) also
reported reduced nasal antibody titres in 2 calves infected with smaller
doses of PIj*
The results of the intradermal test were inconclusive since no
positive control situation was available to test the efficacy of the
skin test antigen. It is possible that the antigen was denatured in
some way, although it did have a HA titre. Recent findings in the
.
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PAST 2
Antibodies and Immunoglobulins in the Serum and Nasal Secretions




In this experiment serum and nasal antibody titres were assayed
in SPF lambs, inoculated with live or inactivated PI^ given either IN
or IM. Any protection afforded by either of these types of vaccination
was then assessed by exposing the animals to an aerosol of live virus.
Serum and nasal secretion IgA, IgG and IgM levels were estimated in
an attempt to discover which immunoglobulins were participating in the
response.
Scheme of Experiment. Twenty-seven 10 day old Dorset SPF lambs were
randomly placed in 5 groups of b and 1 group of 7 (Table 7)• Group 1
was inoculated IN and Group 2 IM with fluid containing lO^TCID 50 Pl^/rnl.
Inactivated virus, prepared from an aliquot of the same fluid, was
administered by similar routes to Groups 3 and b respectively. The
inoculum volume was 2.0 ml per lamb given either as a single IM
injection into the hind leg or as 1.0 ml instilled into each nostril.
Groups 5 an<3 6 were not vaccinated. Tv/enty-five days after vaccination
all lambs except those in Group 6 were challenged by exposure to an
aerosol of live virus. It was estimated that each lamb inhaled
b 9
approximately 10 TCID 50. All lambs were swabbed daily for 1 week
following vaccination and for 10 days after challenge, and during
these periods clinical observations and rectal temperatures were noted
daily. Blood and nasal secretion samples were collected at weekly
intervals after vaccination. All lambs were killed at the end of the
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Table 7, Scheme of Experiment,
Group No. No. of Lambs. Vaccine Route & Aerosol Challenge
?.vpe..
1. 4 Live IN +
2 4 Live IM +
3 4 Inactivated IN +
4 4 Inactivated IM +
5 4 None +
6 7 None —
T.«ble 8.__ Titre of virus recovered from the nasal swabs of Group 1
after IN inoculation of 10 TCID,--. PI 3._L_ 50
Days after inoculation.
Lamb No. 1 2 3 4 5 6 7
25 0.66* >3.0 4.0 3.75 >5.0 4.0 2.5
27 - 1.66 2.0 2.33 4.66 2.66 1.5
28 - NT - 0.66 1.66 .1.66 2.3
29 0.33 1.8 2.1 2.5 4.33 2.0 1.66
* Log TCID^-q/ 0.2 ml of transport medium
- No virus recovered
NT Not tested
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experiment and pieces of the respiratory tract were removed for
histological examination.
Results
Virus recovery and antibody response
Response to Vaccination. No clinical sign or pyrexia was observed
in any of the lambs except in Group 1 where a mild serous nasal
discharge was noted during the period of virus excretion.
Virus was recovered from all lambs in Group 1 following IN
inoculation with live virus and titration of the swabs showed that
there was an increase in virus shedding from day 2 until day 5 (Table 8).
Neutralising antibody was first detected in the serum 7 days post-
JJUs rvlthc
infection at a group mean titre of 1.8 and increased to a titreA
of 20 at 3 weeks (Fig. 21). Nasal antibody was detected in 3 lnmbs
1^ days post infection at titres of 5) 6 and 11 and was present in
all four lambs by day 21. In Group 2 no virus was isolated from
nasal swabs during the first week following inoculation. However,
a serum neutralising antibody response comparable to that of Group 1
occurred but no antibody was detected in the nasal secretions. Lambs
in Group 3 and those in Group 5 and 6 had no serum or nasal antibody
before challenge, while only low serum neutralising antibody titres
were detected in three of the lambs in Group k (Fig. 21),
Response to Challenge with an Aerosol of Virus
A transient nasal discharge was the only clinically detectable
response to challenge and this was observed only in those lambs shown
to excrete virus (Table 9)«
No virus was recovered in Group 1 and a 2-fold increase in serum
neutralising antibody was evident 3 days after challenge. However, no































































-■ — — ■— —■
Killed IM
0 7 14 21 28 35 42
Days following vaccination
and serum titres returned to prechallenge levels within 17 days,
similarly lambs in Group 2 did not excrete virus following challenge
and demonstrated little rise in serum antibody levels, but in this
group, where vaccination had not induced a nasal secretory antibody
response, neutralising antibody appeared in the nasal secretions by
the third day following challenge and these titres remained at
comparable levels to Group 1 until the end of the experiment.
Virus was recovered from all b lambs in Group 3 on at least 2
occasions in the post-challenge period (Table 9). A nasal antibody
response was detected 3 days after challenge in this group and preceded
the serum response, which rose rapidly to a mean of approximately 128
by 17 days. Three lambs in Group b excreted virus (Table 9) and
serum antibody levels increased very markedly after challenge in all
the animals in this group. Nasal antibody hov/ever was only detected
in one animal at 10 days and 3 animals at 17 days after challenge.
The control lambs in Group 5 all excreted virus which was
recovered on at least b occasions after challenge (Table 9)• A serum
antibody response similar to that following vaccination of Groups 1
and 2 was evident but nasal antibody was not detected by the l?th
day post-challenge. No serum or nasal antibody was ever detected in
any of Group 6 lambs, which acted as controls to indicate any
possible cross-contamination with virus between groups.
Pathology Findings
No gross or histological abnormalities were found in the lungs of
any lamb. No inclusion bodies were observed in sections stained with
Pollack's trichrome. Submucosal accumulations of polymorphonuclear
leucocytes were found in some sections of nasal mucosa obtained from
both challenged and control lambs. These lesions were attributed to
inflammatory changes associated with the trauma of nasal swabbing.
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Table 9. Virus recovered from nasal swabs of Groups 5. 4 and 5
after chal.lenge.
Lamb
No. 1 2 3 4 5 6 7 8 9 10
Group 3 20 + f
Inactivated
IN 21 - - - ~ + + - - - -
22 - _ + + + + - - -
24 - - - - - + + - - -
Group 4 5 + + +
Inactivated
IM" 6 - - - - - - - - - -
8




- - - - -
Group 5 11 + + + +
Controls
12 — — - + + + + - - -
13 - - + - + + + + - -
30 - - NT + + + + + + -
+ Virus recovered
- No virus recovered
NT Not tested
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Immunoglobulins Participating in the Pesponse
Serum. Low levels of IgG and IgM were detected in the first serum
samples collected 7 days after vaccination when the lambs were 17 days
old. IgA was not found in these sera and was rarely detected in
later samples (Fig. 22).
IgM was the predominant immunoglobulin in all sera on day 7 with
individual levels ranging between 11 and 37 mg/100 ml in all the
groups except No. 1 v/here higher levels (V? - 88 mg/100 ml) were
recorded. Individual lamb IgG levels ranged from 2.7 to 20 mg/100 ml
(cattk
on this day. Mean IgG and IgM concentrations in the control lambs
A
(Group 6) rose at similar rates until day 28 when IgG increased more
rapidly than IgM so that both immunoglobulins were at similar
concentrations on days 35 an(^ ^2.
The IgM and IgG concentrations in Group 5 were equivalent to
Group 6 until 3 days after challenge when IgM increased rapidly,
reaching a peak at 120 mg/100 ml on day 35- This rise coincided
with the appearance of serum antibody but no concomitant IgG
increase, relative to the controls, was observed.
In Groups 3 an(i IgM an(J IgG concentrations similar to the
controls were detected until after challenge when sharp increases
in IgG, corresponding to the secondary antibody response, were
apparent.
Seven days after IN infection with virus, the mean serum IgM
concentration (6l mg/100 ml) in Group 1 was higher than in the
control groups. Somewhat higher concentrations of IgG were noted
in 2 animals on this day, but by day 21 mean IgG concentrations
were approximately twice that of the control groups. After
challenge the concentration of IgG overtook that of IgM and
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Individual lambs in Group 2 showed varying IgG and IgM responses
(Fig. 23). Although no high initial IgM level was noted, in lambs 2
and h IgG increased sharply to a peak concentration on day 21. After
challenge neither of these animals showed a secondary IgG rise although
lamb k did show an increase in IgM levels. In Lamb 1 no rise in IgG
occurred on day 21 but this immunoglobulin did increase sharply
between days 35 and ^2. Lamb 3 showed a response intermediate between
these extremes with smaller increases of IgG on day 21 and after
challenge.
Nasal Secretions.
Immunoglobulin was only detected in the occasional nasal secretion
sample collected on day 7 (Fig. 2h). IgA and IgG were detected in '4 of
the control animals (Groups 5 and 6) on day 1'4 at between 2 and k mg/100 ml
and IgM was found at similar concentrations in k of these lambs. In
Group 6, IgA marginally predominated on days 21 and 28, becoming the
major immunoglobulin constituent on days 35 and '+2 with mean concentrations
of approximately 8 and 11 mg/100 ml respectively (Fig. 2'+).
With the possible exception of Group 1, all the other groups
showed a similar pattern, with IgA usually predominant especially on'
days 35 and '42. In Group 1 the mean concentrations of all 3
immunoglobulins were greater on days l'+ and 21, which coincided with
the detection of nasal antibody. However in the other groups no
correlation between immunoglobulin concentration and nasal antibody
was observed.
Discussion
The absence of clinical signs or pathology in SPF lambs following
exposure to PI either IN, IM or by aerosol emphasises the mildness
of experimental infection with this virus. Thus virus excretion from
the nose was the criterion used for assessing any protection conferred
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by vaccination. Using this criterion, this experiment showed that live
virus given either IN or IM was protective, whereas inactivated virus
administered by either of these routes was not. Similar serum antibody
levels followed inoculation of live virus either IN or IM. Lower
levels were detected after IM administration of inactivated virus and
no antibody was stimulated by inactivated virus IN.
HI activity was found in the control lambs' nasal secretions and
therefore the HI test was not used to detect antibody. Nasal secretion
neutralising antibody was detected only after IN vaccination with live
virus. However after challenge, nasal antibody appeared more rapidly in
Groups 2, 3 and 4 than in the control group (Group 5)» suggesting that
lambs may be capable of an anamnestic nasal antibody response. It is
not clear why the lambs in Group 1 did not show such a response, but
this may indicate that the immunity of this group was more solid and
that these lambs were not infected. Responses, similar to the nasal
antibody changes found in Groups 1 and 2, have been reported in
calves (McKercher et_al, 1972).
The IgA, IgM and IgG determinations made on Groups 5 an^ 6
provide information on the ontogeny of the immune response in the
serum and nasal secretions of colostrum deprived lambs. At first IgM
was the major serum immunoglobulin but within a few weeks IgG became
predominant. No immunoglobulin was detected in the nasal secretions
until the lambs were about 3 weeks old. During the next 2 to 3 weeks
all three immunoglobulins were present in approximately equal
concentrations, before IgA emerged as the predominant immunoglobulin
class.
After Groups 3i ^ anc^ 5 were challenged, IgM was clearly
associated with the primary serum antibody response and IgG with
the secondary response. The reason for the individual variation
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in the Group 2 lambs' serum immunoglobulin response is obscure.
In the nasal secretions it was not possible to correlate changes
in immunoglobulin concentrations with detection of antibody. This was
probably due to the considerable variation in immunoglobulin levels
found in individual nasal secretion samples, as described previously
in conventional sheep (Section II part 2 and this section, part I).
Unfortunately not enough fluid of sufficiently high antibody activity
was available to permit fractionation of the nasal secretions.





A single inoculation of inactivated virus stimulated a poor
antibody response in the lambs in Experiment 1. This second experiment
was carried out to test the effect of 2 inoculations of inactivated
virus, given either IN or IM, with the IM dose emulsified in FCA. The
effect of giving the first vaccine IM followed by an IN 'booster'
without adjuvant was also investigated. Any immunity conferred by
vaccination was assessed as before by challenging the lambs with an
aerosol of virus. Attempts were made to determine the immunoglobulins
participating in the response.
Scheme of Experiment. Sixteen, 10 day old, cross-Suffolk SPF lambs were
randomly placed into equal sized groups numbered 7, 8, 9 and 10
(Table 10). Group 7 was vaccinated IM with 2 doses of inactivated virus
emulsified in an equal volume of FCA. Group 8 lambs received 2 IN
doses of the same vaccine, without adjuvant but diluted in an equal
volume of P3S. The lambs in Group 9 were inoculated first IM with
vaccine in FCA and then IN without adjuvant. The interval between
vaccinations was 3 weeks. The lambs in Group 10 were not vaccinated.
g
Prior to inactivation the titre of the vaccine was 10 TCID 50/ml.
The volumes inoculated were 2.0 ml IM and 1.0 ml into each nostril.
Six weeks after the first vaccination all the lambs were challenged,
group by group, by exposure to an aerosol of live It was estimated
that each lamb inhaled 10^*"^ TCID 50 of virus. All lambs were swabbed
daily for ten days after challenge and during this period clinical
observations and rectal temperatures were noted. Blood and nasal
secretion samples were first taken prior to vaccination and at weekly
intervals thereafter. The samples were assayed for neutralising
antibody and immunoglobulin concentrations. A serum sample and
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TAB LB 10. Scheme of Experiment,
Group No. 1st Vaccination 2nd Vaccination Aerosol
Challenge
7 Inactivated IM + Inactivated IM + +
FCA FCA
8 Inactivated IN Inactivated IN +
9 Inactivated IM + Inactivated IN +
FCA
10 None None +
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a pool of nasal secretions both collected from Group 9 lambs just
before challenge were fractionated by gel filtration to determine
the immunoglobulin classes associated with the anti-viral activity.
Results
Response to Vaccination
Following the vaccination of Group 7, serum antibody was first
detected in all the lambs l'+ days later at a mean titre of about 13
(Fig. 75). Serum antibody titres continued to increase after the
second vaccination reaching a mean of about 200 on day h2. Meanwhile
nasal antibody was first noted 7 days after the first vaccination
of this group and these secretion titres continued to rise after the
'booster' to a mean of almost 8 prior to challenge.
Group 9 lambs responded as those in Group 7 after the first
vaccination. Following the IN instillation of inactivated virus,
serum and nasal antibody appeared to rise more rapidly than Group 7»
but the nasal titres of both groups were at similar levels by the
day of challenge.
No detectable serum or nasal antibody response occurred in
Group 8 following either vaccination.
Resporse to Challenge
Within approximately 2 hours of challenge all the lambs in Group 9
and 2 lambs in Group 7 were showing varying degrees of dullness,
pyrexia and dyspnoea, and had rales and rhonchi. These signs
gradually disappeared and within 3 days all lambs appeared clinically
normal, except one in Group 9, which still had a respiratory lift.
These signs resembled an immediate-type hypersensitivity
reaction which may have been caused by the animals being exposed
to an aerosol of antigen to which they had previously been
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and IN vaccinated lambs (Group 8) were clinically normal following
challenge, except for some nasal discharge. Similar amounts of virus
were recovered from the lambs in these two groups (Table 11). Virus
was never recovered from Groups 7 or 9•
By 12 days after challenge the mean nasal antibody levels in
Group 7 increased approximately ^ fold, whereas little rise in titre
was observed in Group 9. However, the mean serum antibody level in
Group 7 fell slightly on day b9 but rose to about 1000 by day ^b.
In Group 9, on the other hand, mean serum titres increased to
greater than 102^ on day b9 and fell 2 fold by day 5^.
Twelve days after aerosol exposure all the Group 8 lambs had
serum titres of k but only one lamb had detectable nasal antibody.
Low serum antibody titres appeared in the control lambs' (Group 10)
sera 12 days after challenge, but nasal antibody was not detectable
at this time.
An attempt was made to discover the antigen(s) likely to have
caused the hypersensitivity reaction in Groups 7 and 9» Gel diffusion
tests showed that sera from lambs in these 2 groups had precipitating
antibodies to horse serum, but not to any other constituents of the
challenge inoculum or to lamb serum. No precipitins to horse serum
were detected in the nasal secretions of the lambs. However, it was
thought likely that the anaphylactic type reaction was due to horse
serum antigens. Thus on day 52 of the experiment, 2 lambs in Group 9
were rechallenged with an aerosol of PI grown up with medium
containing 2% lamb serum and 2 lambs were rechallenged with identical
medium, but without virus, and containing 2% horse serum.
Within an hour of challenge both pairs of lambs appeared dull
and showed similar signs to those following the first challenge.
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Table 11. Titre of Virus recovered from nasal swabs from lambs in
Groups 8 and 10 after challenge.
Lamb No. 1 2 3 4 5 6 7 8 9
10 1.5* 1.0 0.7 0.5
Group
8 11 — 0.25 0.25 3.0 3.0 3.3 0.5 0.5
:.N. + I.N.
13 - 0.15 1.7 2.3 1.0 3.3 0.15 - -
14 - - 0.25 2.0 2.0 1.3 0.15 0.25 -
1 2 , 0.15 0.5 2.5 0.7 1.3 0.15 0.15 -
Group
10 15 0.15
- 0.25 1.0 1.5 0.3 - 0.15 -
Controls 16 - 0.15 0.3 1.0 2.5 1.3 0.25 -
17 - - 0.5 1.5 1.0 1.5 - -
Log TCIDj-q/.2 ml transport medium.
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In addition, each of the pair exposed to virus had a very marked
frothy nasal discharge, a sign not shown by the lambs exposed to
horse serum. As was the case after the initial challenge, abnormal
clinical signs had disappeared by 2 days, except for the same lamb
as before, which still had a respiratory lift.
Immunoglobulins Participating in the Response
Serum
In the control lambs (Group 10) IgM was the major serum
immunoglobulin at the beginning of the experiment with a mean
concentration of 100 mg/100 ml (Fig. 26), but this decreased
progressively until 7 days after the aerosol challenge when it
increased from 35 mg/100 ml to SO mg/100 ml. Mean IgG concentrations
increased quickly from 20 mg/100 ml at day 0 to exceed IgM by day l'+,
reaching 'tOO mg/100 ml by day '+2.
An essentially similar pattern was observed in Group 8 except
that the mean initial IgM concentration was lower (30 rng/100 ml)
and the increase in serum IgG occurred 1 week later. Like Group 10,
both IgM and IgG increased after the challenge exposure and IgA
was only occasionally detected at very low concentrations in the sera.
Seven days after vaccination with FCA, Group 7 lambs had higher
serum IgM concentrations than the controls, increasing to 115 mg/100 ml
by day l'+ and thereafter fluctuating between 80 and 110 mg/100 ml.
From day 7 onwards IgG increased much more rapidly than in the
controls and this increase continued throughout the experiment
reaching a mean of 1,350 mg/100 ml by day 5^.
Serum immunoglobulin concentrations were very similar in
Group 7 and 9 following vaccination v/ith adjuvant. After the
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increased more rapidly than Group 7 to reach some 1000 mg/100 ml by
day 28. Thereafter IgG in both groups increased at approximately
similar rates so that Group 9 IgG concentrations were always some
200-300 mg/100 ml greater. Despite the high concentration of IgG
and IgM, IgA was usually not detected in the sera of Groups 7 and 9•
Nasal Secretions
Immunoglobulins were not detected in any of the first nasal
secretions samples collected. In the control lambs (Group 10) IgA
and IgG were first detected on day l4 and similar mean concentrations
of these immunoglobulins, ranging between 5 and 10 mg/100 ml, were
detected throughout the experiment (Fig. 27). IgM was detected in
most nasal secretions taken after day 21 at mean concentrations
less than 5 mg/100 ml. The pattex^n observed in Group 8 was very
similar except that higher concentrations of IgG were detected
after the aerosol challenge.
Following the administration of adjuvant vaccine to Group 7 and 9»
all 3 immunoglobulins were detected at higher mean concentrations than
in the control lambs. After the second vaccination IgA and IgG
concentrations in Group 7 continued to increase at similar rates
each reaching some 10 mg/100 ml by day 42, whereas IgM concentrations
decreased to a mean of 2 mg/lOO ml over this period. However, by 1
week after the IN booster, a steep increase in IgG was observed in
Group 9 continuing to day 35 when the mean IgG concentration was
estimated at 32 mg/100 ml. An increase in nasal secretion IgA
was also found in these lambs after the booster but this occurred
1 week after the IgG rise. IgM also increased during this period
but like the IgG response a decline was noted between days 35
and 42. Following the aerosol challenge, increases in IgG and IgM
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greater in Group 9.
Fractionation of serum and nasal secretions.
A prechallenge serum sample from a lamb in Group 9 was filtered
through the column of Biogel (Fig. 28). Neutralising and HI titres
correlated closely and the antibody activity was confined to the 2
protein peaks which contained IgM and IgG, the bulk of activity being
associated with IgG; IgA was not detected in any fraction.
A pool of prechallenge nasal secretions from Group 9 lambs was
fractionated in an identical manner. Two peaks of anti-viral
activity were resolved, corresponding to those observed with serum
(Fig. 29). After 8-fold concentration, each fraction was tested for
immunoglobulin content and re-titrated for anti-viral activity. Even
after concentration no antibody was detected in the fractions
containing IgA.
Samples of the serum and the pool of nasal secretions were analysed
on immunoelectrophoresis with anti-IgG serum (Fig. 30). IgG^ and IgG^
precipitin arcs were resolved in the serum samples, but only IgG^ was
found in the nasal secretions:
Pathology
Post mortem findings. All lambs which had been inoculated with adjuvant
had fibi-ous lesions and small beads of pus at the injection site. The
lungs of the animals in Group 9 were rather heavy and oedematous. The
lungs of lamb No. 6, which was clinically ill at slaughter were also
consolidated along the costal margins of the diaphragmatic lobes and
excess frothy material was present in the larger airways. No gross
abnormalities were detected in the remaining lambs' lungs.
Histological findings.
Lung. No abnormal histological features were seen in the lung sections
made from Groups 9 a^d 10,although erythrocytes were often present in
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Fig. 28 Fractionation of serum by filtration through
Biogel A 1.3
Sample: 2 ml of serum collected from lamb No. 5
in Group 9 on day b2.












































Fig. 30 Immunoelectrophoresis of serum and nasal
secretions obtained from Group 9 on day b2.
upper and lower wells; nasal secretions.
centre well; serum.
troughs; anti-IgG.
The anode is on the left.
the airways due to inhalation of blood at slaughter (Fig. 31). No
inclusion bodies were detected even in sections stained with Pollack's
trichrome. Mild perivascular and peribronchiolar'cuffing'caused by
accumulation of lymphoid and mononuclear cells was the only abnormality
detected in the lung sections of Group 7 (Fig. 32). This feature was
also found in Group 9 lambs in addition to patches of interstitial
pneumonia caused by invasion of lymphoid and mononuclear cells into
the alveolar septa (Figs. 33 and 3^). These lesions tended to be
distributed near bronchioles but polymorphonuclear leucocytes were common
throughout much of the tissue, often within the lumen of the bronchioles.
These features were found to a similar degree in both of the pairs of
lambs in this group.
Nasal mucosa, trachea and bronchus. Focal submucosal accumulations of
polymorphonuclear leucocytes were usually observed in sections of the
nasal septa taken from all groups of lambs. These were probably due to
an inflammatory reaction following the trauma of nasal swabbing.
Compared with the other groups, increased numbers of eosinophils and
polymorphonuclear lymphocytes were seen in the nasal, tracheal and
bronchial submucosae of the Group 9 lambs.
Discussion
In contrast to the results of Experiment 1, it was found that
inactivated virus given with FCA by the IM route stimulated high antibody
titres in both the serum and nasal secretions and these titres increased
to very high levels after a second vaccination, either IM with FCA
or IN without adjuvant. Nasal antibody titres were greater, albeit
temporarily, when the second inoculation was given IN. However 2 IN
instillations of inactivated virus did not stimulate any detectable anti¬
body and these lambs and the control group shed similar quantities of
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Fig. 31
l* % i ) --*•• Y 'iS i-4^'4' V ;:
. ■*• . * . -^v'< . J|r *k ,-^S v>«4 £ "T*^/ -)>y V*..;
* /* • , ,r,
]-irfi * . - A' n->
A' )?' • r 1
i t t-V'' -i»vW '^-"
l Hd- . >>4,„ r ' -A *, 'l&
£*.\ V- W. \.V vT %XjV^ w.
'•"' *•". „i, > "« "^ijL Y'V ■•'/ T ^'-'H «sR
Ejft #*V-
I,,Mf./- ; f '
*Hr- a
&0''" - t'Y^
•/« *\ « ••*. ^ . ,
A /fr •?...
Normal lung from lamb No. 13 in Group 10 (magnification
x 60). Erythrocytes are present in the bronchioles due
to backbleeding at slaughter.
Fig. 32
Lung from lamb No. k in Group 7 (magnification x 6o).
A mild peribronchiolar accumulation of lymphoid and
mononuclear cells can be seen.
—— Lung from lamb No. 8 in Group 9 (magnification x 60).
This animal was rechallenged with PI^ in serum-free
medium. This section shows interstitial pneumonia caused
by invasion of lymphoid and mononuclear cells into the
alveolar septa.
-2— Lung from lamb No. 6 in Group 9 (magnification x 60).
This lamb was rechallenged with horse serum. The
section shows interstitial pneumonia distributed mainly
near bronchioles. Polymorphonuclear lymphocytes are
present in the lumen of one bronchiole.
virus after challenge. Again, despite replication of the virus,
abnormal clinical signs were not observed in the control lambs after
challenge. No viral inclusion bodies or pathological changes were
observed in histological sections taken from these animals' lungs.
This was not surprising since Stevenson (1968) could only detect
inclusion bodies up to 8 days after infection.
However the hypersensitivity reactions and lesions shown by the
lambs in Groups 7 and 9 after challenge were unexpected. On the other
hand FCA alone has been found to produce mild peribronchiolar 'cuffing'
in calves (Wells, 1972) and anaphylaxis has been elicited in sheep,
immunised with antigens in FCA (Alexander.et al, 1970; Ladiges et al,
197*0 • In addition, experimental anaphylaxis with similar histological
changes has been produced in sensitised cattle exposed to aerosols of
the sensitising antigen (Dungworth, 1965). Similar cellular reactions
to those seen in Group 9 lambs have been described by Bartlema and
Fontages (1973, citing Karelse, 1970) in respiratory immunisation studies
with mice. Following intratracheal vaccination with tetanus toxoid with
a Bordetella pertussis adjuvant, Karelse found interstitial pneumonia
with perivascular infiltration of cells. This cellular infiltration
initially consisted of leucocytes but in later stages was predominantly
mononuclear cells. Unfortunately it was not clear whether viral anti¬
gens were involved in the reactions seen in the experiment here.
Obviously it would be of considerable importance to know if such a
reaction could occur in naturally exposed lambs which had been immun¬
ised by this method.
It is not clear why serum immunoglobulin concentrations were
considerably greater in the control animals in this experiment compared
with Experiment 1. Although these lambs were SPF, certain species of
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bacteria could be recovered from nasal and rectal swabs (Mr. D. Thompson
personal communication). It is possible that the lambs in this experiment
were colonised earlier or more heavily with bacteria than those in
Experiment 1, a situation which might have stimulated increased immuno¬
globulin levels.
FCA stimulated high serum IgG levels v/hich paralleled the steep
rise in antibody titre and fractionation confirmed that the bulk of
antibody was associated with this immunoglobulin. Fractionation of
the nasal secretions from lambs which had been immunised IM with FCA
resolved the anti-viral activity into 2 peaks. From other results
(Sections III and IV) most of the first peak of activity was probably
due to non-specific inhibitors, although IgM antibody may also have
been involved. However the remaining peak of activity was associated
with IgG^ and even after concentration no activity was found in fractions
containing IgA.
It is known that IgG^ is selectively transferred from serum into
the colostrum and milk of the ruminant (MacKenzie and Lascelles, 1968;
Murphy et al, 196^) and recently Watson and Lascelles (1973 b) have
demonstrated that IgG-^ is selectively transported into sheep saliva.
Using radiolabelled immunoglobulins similar results have been obtained
in the bovine with tears (Pedersen, 1973) and various other secretions,
including respiratory fluids (Curtain et al, 1971)• From this evidence
it seems probable that the effect of FCA in this experiment was to
stimulate very high circulating IgG antibody levels and that IgG^
antibody was selectively transferred into the nasal secretions.
However part of the IgG in the nasal secretions may have been locally
produced, since pieces of bovine nasal mucosa cultured in vitro with




The last experiment showed that high serum and nasal antibody
titres could be stimulated and protection conferred in lambs either,
1) by two IM vaccinations with inactivated PI in FCA, or 2) by one IM
vaccination with inactivated PI in FCA followed by IN instillation of
inactivated virus without adjuvant. The object of this third
experiment was to find out whether a single IM vaccination of inactivated
PI^ in FCA would be protective.
An anaphylatic like response occurred in the last experiment in
those lambs which had been vaccinated with FCA. However it was not
clear whether viral antigens were involved. In order to reduce the
presence of non-viral antigens, the virus used for vaccination and
challenge in this experiment was propagated in serum-free medium.
The possibility of an anaphylactic reaction occurring after challenge as
a result of hypersensitivity to non-viral antigens, was controlled by
vaccinating a second group of lambs with virus-free medium emulsified
in FCA.
Scheme of Experiment
Eight 10 day old, Blackface SPF lambs were randomly placed into
2 equal sized groups numbered 11 and 12. Lambs in Group 11 were
vaccinated with control fluid and Group 12 was vaccinated with inactivated
PI^. Both vaccines were emulsified with an equal volume of FCA and
•were injected in 2 ml volumes IM into each lamb's left hind leg. Three
weeks after vaccination both groups of lambs were challenged by exposure
to aerosol.
7
A pool of infective material containing 10 TCID 50/ml of PI^ was
prepared as before except that serum was omitted from the culture
medium. Control fluid was prepared from uninfected Roux cultures
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maintained in parallel with the same medium. Aliquots of the virus pool
were inactivated as described previously. Aliquots of the virus
pool which had not been inactivated were nebulised to produce the
challenge aerosol. As in previous experiments the lambs were swabbed
for virus isolation and clinically examined for 10 days after the
challenge. Weekly blood and nasal secretion samples were collected
from the lambs and assayed for virus neutralising antibody and
immunoglobulins. A pool of nasal secretions was fractionated as
described previously.
Results
Response to vaccination. In Group 12 serum antibody was first detected
l'f days after vaccination at a mean titre of 60 increasing to almost
512 by the day of challenge (Fig. 35) • Nasal antibody was also
observed on these days at mean titres of approximately 3 and 6
respectively. No antibody was detected in the sera taken from Group 11
lambs before challenge although low levels of anti-viral activity were
noted in the nasal secretions on days l'( and 21.
Response to challenge. Two point five ml of infective fluid containing
7.5
10 * TCID 50 virus/ml were nebulised during each exposure period.
However no virus was recovered from a 10 minute impinger sample collected
when Group 11 was being challenged. No clinical signs were noted after
this challenge and no virus was recovered from the nasal swabs from any
of the lambs. However a mean serum antibody titre of about 128 was
detected l'+ days after challenge in the control group (No. 11) and this
increased almost 2 fold by day bZ of the experiment. In the nasal
secretions of this group antibody increased temporarily to a mean titre
of about 5 before falling to the low pre-challenge levels. In Group 12
meanwhile, mean serum titres increased 2-fold 7 days after the
challenge but declined on days 35 and bZ to about the pre-challenge

















level (hOO). A continuous rise in nasal secretion antibody was noted
after challenge in this group and mean titres reached 6k by the end of
the experiment (Fig. 36).
Immunoglobulins participating in the response.
a) Serum. As in the 2 previous experiments IgM concentrations were
higher than IgG in the first serum samples examined although the
absolute concentrations of both proteins were considerably greater than
in previous groups at mean levels of about 175 and 75 mg/100 rnl
respectively (Fig. 56). After the administration of FCA IgG concen¬
trations in all the lambs increased rapidly to group mean levels of
some ^00 mg/100 ml on the day of challenge. IgM levels however-
declined at similar rates in both groups as the experiment progressed.
Following challenge an increase in IgG levels was observed in Group 12
but not in Group 11. IgA was not detected in any sera in this
experiment.
b) Nasal Secretions. Except for a few samples in which very low levels
were found, immunoglobulin was not detectable in the first nasal
secretion samples collected from these lambs (Fig. 37). IgA
concentrations soon increased and from day 21 onwards were at similar
mean levels in both groups of lambs (5 to 10 mg/100 ml). The group
mean concentrations of IgM were also similar, but at lower levels than
IgA, fluctuating between 1 and 5 mg/100 ml. IgG was the major nasal
immunoglobulin in both groups by l'f days after vaccination and
concentrations were similar in both groups before challenge. Two weeks
after the aerosol challenge however, a marked increase was observed in
Group 12 IgG' concentrations compared with Group 11, when the respective
































Pre-challenge nasal secretions from group 12 were pooled and filtered
through the Biogel column. HI activity was separated into 2 peaks
(Fig. 38) • The first peak was eluted at the exclusion volume, in
association with IgM. The second peak coincided with the IgG fractions.
Little activity was associated with the IgA containing fractions.
Discussion
The nasal and serum antibody response following vaccination of
Group 12 lambs was similar to that following the first vaccination of
Groups 7 and 9« Some neutralising activity was observed in the nasal
secretions from Group 11 lambs, but this activity was so low that it was
of doubtful significance.
Since no virus was recovered in the impinger sample or from the
nasal swabs of the control lambs , it appeared that the challenge aerosol
had failed. However the sharp increase of serum antibody in Group 11
after challenge clearly indicated that the control lambs had inhaled virus
antigen, which presumably was not infective. It seems likely that the
virus was,inactivated during or after nebulisation. The reason for this
is not known; possibly PI^ virus in serum-free medium is unable to with¬
stand nebulisation. Since virus was not recovered from the control group,
it was obviously not known whether the vaccination would have protected
Group 12. Although virus antigen was inhaled after challenge, no
anaphylactic type reaction was observed in any lamb. This suggests that
the reactions seen in Experiment 2 may not have been caused by hyper¬
sensitivity to viral proteins.
Following IM administration of FCA, IgG became the major nasal
secretion immunoglobulin as found in Experiment 2. As previously
discussed, the high nasal secretion IgG levels may have been due to
selective transport of IgG^ from the serum. Fractionation of the nasal
secretions also produced identical results to those in Experiment 2,
Fig38Fractionationfnasalsecretionsbyfiltratioth u hBiogeA1.5M. Sample:klofnasalsecretionscollect dfr mGroup12bef rh llenge. Column:70x2.5c .Fractiosize11ml
 
with all the antibody activity confined to the IgG containing fractions.
The first peak of HI activity was probably due to non-specific inhibitors
(see part 1 of this Section and Section IV, part 2).
Of interest was the finding that the post challenge serum titres
in the control group were very high, similar to those following
vaccination of Group 12. Thus, when FCA was inoculated 3 weeks before
the antigen and by a different route, the serum antibody response was
comparable to that following simultaneous administration of antigen
and adjuvant at the same site. However no such similarity was
observed in the nasal secretion antibody response. If the antibody in
the nasal secretions was largely derived from serum, why, in the
presence of similar serum antibody titres, were the post challenge nasal
secretion titres in Group 11 lower than the post vaccination nasal
titres in Group 12? One possible explanation is that following
vaccination of the immunologically virgin Group 12 lambs, a relatively
high proportion of serum IgG^ would have anti-PI specificity, whereas
following challenge of Group 11 this proportion would be lower. There¬
fore in Group 11 more IgG^ molecules of other specificity would be
available in the serum to compete for selective transport into the




The Immune Response of Newborn Suckled Lambs following Intranasal
Challenge with Parainfluenza 3 Virus.
Introduction
The results of the vaccination/challenge experiments with SPF
lambs in Section III showed that the presence of antibody either in the
serum or nasal secretions correlated closely with protection against
infection with PI . However the role if any of cell mediated immunity
was not known. The object of the experiment described in Part I of this
section was to find out'whether lambs passively immunised with antibody
would be protected. The most convenient and most natural situation to
examine was to challenge newborn lambs which had colostral antibody.
Unless infected in ute o or very early in life, these animals could not
have any active immunity to the virus and therefore any protection
conferred could be attributed to the action of antibody alone. In
order to reduce the chance of neonatal infection the lambs were
removed from their dams before they were 1 week old and housed in
isolation. Nasal secretions were also collected from these animals to
investigate whether colostral antibody could be detected in the nasal
secretions.
Materials and Methods.
Lambs. Eight conventionally reared Suffolk lambs, aged between 3 and
7 days, were placed in 2 groups according to their dams' serum HI titres,
assayed approximately 2 weeks before parturition. Four lambs from 3 ewes
with serum HI titres less than 10 and k lambs from 3 ewes with titres
of 20 or greater were placed into Groups A and B respectively. Each
group was housed in a separate loose box and reared on milk substitute*,
* Nutrilamb, Scottish Agricultural Industries, Ltd.
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which contained no detectable immunoglobulin. Protein concentrates and
hay were also available ad lib.
Experimental Scheme. One ml of fluid containing 10^'^ TCID 50 of PI
was instilled into each nostril, when the lambs were between 5 and 9
days old. Virus isolation was attempted from nasal swabs, collected
from the right nostril just before and for ten days after inoculation
v/ith virus. Blood and nasal secretion samples were collected on 2
occasions before challenge, and on days 2, k, 7, 10, l*f and 21 after
challenge. Nasal secretions were collected from the left nostril.
All samples were stored at -20°C before virus neutralising and
immunoglobulin assays were performed.
Results
The results of virus recovery -nd the serum and nasal antibody
titres are shown in Table 12.
Pre--challenge antibody. Although their dams had serum HI titres less
than 10, two of the lambs in Group A (Nos. A03 and 631) had low serum
neutralising titres prior to challenge. However antibody was not
detected in the nasal secretions of these lambs. Group B lambs all had
higher serum titres than Group A before challenge, especially lamb
A02 which had a titre of 20^8. Although Nos. h07 and ho8 were twins,
a 6 fold difference in the serum antibody titres was found. Pre-
chalienge nasal antibody was also detected in the 3 Group B lambs
which had the highest serum titres.
Virus Recovery. No virus was recovered from the nasal swabs taken a
few minutes before inoculation. After the intranasal challenge no
clinical signs were observed apart from the occasional mild nasal
discharge. Virus was recovered on at least one occasion from all
the lambs in Group A but only from two of the lambs in Group B. In











(days) -2 0 2 4 7 10 14 21
A 4o6 b b s2 0" 0 0 0 0 8 23 32
N3 0 0 0 0 0 0 2 0
631 6 7 S 6 6 NT 3 2 4 8 8
N 0 0 0 0 0 0 0 0
(
c




N 0 NT 0 0 0 0 0 0
(
( '\0b 5 1 S 0 0 0 0 2 8 45 32
N 0 0 0 0 0 0 0 0
B b05 3 2 S '45 91 45 32 45 45 32 32
N ■ 16 8 4 4 3 8 6 4
(
c
bo7 b 0 S 91 64 23 32 32 32 45 16.
(
T (
N b 3 0 0 0 0 0 0
(
( 4o8 b 7 S NT 11 11 11 32 16 64 45
N 0 0 0 0 0 0 0 0
b02 7 0 S 2048 2048 2048 2048 2048 i\> O -Pr Co 2048 2048
N 6b 64 NT 8 2 16 6 8
1 2 3.
V = No. of times virus recovered; S = Serum; N = Nasal Secretions;
l±
0 = 2; NT = Not Tested; T = Twins.
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^08, which had the lowest serum and nasal antibody titres of the
group. However virus was only re-isolated once from lamb hok,
although no pre-inoculation antibody activity was detected in the serum
or nasal secretions of this lamb.
Post-challenge antibody. After challenge a k fold or greater rise in
serum antibody v/as observed in 3 lambs in Group A and one lamb in Group
B Except for larrib No. 't0'+, virus had been recovered on at least
occasions from these lambs. No. 631 was also surprising since no
significant rise in serum antibody was detected, despite the fact that
virus was isolated 7 times from this lamb. Nasal antibody v/as only
detected in one post-challenge sample from the lambs which did not
have pre-challenge nasal antibody.
Immunoglobulins in Serum and Nasal Secretions.
Serum. There was considerable variation in the concentration of serum
immunoglobulins in different lambs. This presumably was due to
variation in the amount of colostrum ingested. Thus lamb boy had
about '+ fold higher levels of all 3 immunoglobulins than its twin.
Lamb 631, which was one of quadruplets, had the lowest IgG and IgM
levels at the start of the experiment (Tables 13, l'+ and 15).
IgG constituted about 30% of the serum immunoglobulins and IgG
levels declined during the 3 week period of the experiment. The decline
in serum IgG v/as less marked in the 2 lambs with the lowest initial IgG
concentrations (Nos. 631 and ^08). Serum IgM levels also showed a
downward trend in most lambs as the experiment progressed. However
serum IgM levels in lamb 631 increased by the end of the experiment.
IgA was detected in 6 lambs' sera collected 2 days before challenge.
However serum IgA rapidly disappeared and was not detected later than
2 days after challenge.
Nasal Secretions. High levels of IgG were found in the lambs' nasal
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Table 13.








-2 0 2 4 7 10 14 21
A 4o6 4 6500 3900 2500 2750 4000 4200 1900 1500
631 6 500 320 ND 290 330 ND 320 320
(403 5 2'+00 2000 2100 1600 1450 1450 1400 1100
Twins (
(404 5 1800 1700 1750 1600 1700 1700 1200 1000
B 405 3 17C0 1500 1150 1300 1250 1250 680 390
(407 4 3000 4500 4200 4500 2350 1700 2150 1700
Twins (
(4o8 4 810 780 780 690 ND 430 810 600
402 7 2000 1700 1900 2000 2100 1900 1700 1650
IMMUNOGLOBULINS IN NASAL SECRETIONS MG/lCO ML
406 4 170 150 54 80 100 66 50 24






5 390 130 38 ND 54 52 30 22
5 250 80 45 23 14 17 17 4.7




4 230 110 130 95 64 66 39 43
4 54 54 ND 21 20 13 12 10.5
402 7 230 95 150 90 26 66 27 47
ND = not done
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Table 1'-+.
IMMUNOGLOBULINS IN SERUM MG/lOO ML
Group Lamb Age at IgM
Number D-2
v Days after Challenge
-2 0 2 4 7 10 14 21
A 406 4 350 320 200 180 170 200 78 52
631 6 83 27 ND 98 45 119 45 60
(403 5 230 180 190 126 144 105 112 60
Twins (
(404 5 190 119 105 98 126 83 56 25
B 405 3 116 51 49 35 32 22 15 10
(40? 4 420 420 170 270 170 105 98 85
Twins (
(4o8 4 128 102 78 56 43 37 30 34
402 7 170 210 119 86 76 71 102 42
IMMUNOGLOBULINS IN NASAL SECRETIONS MG/lOO ML
A 406 4 6.1 4.5 4.7 0 ND 0 3-9 0
631 6 ND 0 0 0 0 8.1 ND 0
(403 5 5.1 3.7 0 ND 0 3.7 0 5-7
Twi rs (
(-'',04 5 7-1 0 0 0 0 0 0 0




0 0 6.3 0 0 0 0
(407 4 17 CO• 9.5 6.1 9.5 5.9 5.2 ND
Twins (
(4o8 4 0 0 0 0 3-7 3.9 4.2 0
'402 7 9.5 6.8 9.5 5.1 8.4 4.2 0 3.7
ND = not done
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Table 15.
IMMUNOGLOBULINS IN SERUM MG/lOO ML
Group Lamb Age at IgA
Number (D-2 —
(Days) Days after Challenge
-2 0 2 4 7 10 14 21
A 4o6 4 22 8 4.8 0 0 0 0 0
631 6 9.6 4.6 0 0 0 0 0 0
C+03 5 0 0 0 0 0 0 0 0
Twins (
(4o4 5 7.2 0 0 0 0 0 0 0
B 405 3 9.6 0 0 0 0 0 0 0
(407 4 46 13 5.8 0 0 0 0 0
Twins (
(4o8 >} 12 0 0 0 0 0 0 0
402 7 0 0 0 0 0 0 0 0
IMMUNOGLOBULINS IN NASAL SECRETIONS MG/lOO ML
A 406 4 0 0 0 0 0 6.0 4.8 4.1
631 6 ND 0 0 0 6.0 6.0 ND 4.7
(403 5 0 0 0 ND 0 0 0 0
Twins (
(4o4 5 0 0 0 0 0 0 0 0
B 405 3 0 0 0 0 0 0 6.0 6.0
(407 4 4.2 0 0 0 3.8 4.2 6.0 ND
T wins (
(4o8 4 0 0 0 0 0 6.7 8.7 6.7
402 7 0 0 5.5 5.1 7.9 10.4 7.2 8.7
ND = not done
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secretions. Nasal secretion IgG levels declined as the lambs grew
older. IgM was detected at low concentrations in pre-challenge nasal
secretions from 6 lambs. In 2 lambs (k02 and '(07) IgM was detected
regularity, but in the remaining animals the levels were usually
below the limits of detection. IgA was found in one nasal secretion
sample prior to challenge. However IgA was detected regularity in the
nasal secretions of 6 lambs aged 2 weeks or more. On the other hand, no
IgA was found in the secretions of one pair of twin lambs (Nos. ;403 and
bok) throughout the experiment.
Discussion.
The number of lambs involved in this experiment was too small to
draw any firm conclusions. However it seemed that high titres of
passively acquired nasal secretion and serum antibody could protect
against PI infection. Thus virus was recovered on only 2 occasions
from the 3 lambs which had minimum pre-challenge serum and nasal titres
of 6k and 3, whereas 27 isolations were made from 5 lambs which had
maximum serum titres of 11 and no detectable nasal antibody. In
addition '4 of these 5 lambs showed a k fold rise in serum antibody after
challenge, while no increase was detected in the 3 animals with the high
pre-challenge titres. Thus all four of the lambs taken from ewes with
undetectable serum titres were susceptible to the virus challenge, while
only one of the k lambs from dams with serum antibody was susceptible.
The fact that this susceptible lamb (No. ^08) had an immune sibling
shows that the quantity as well as the quality of colostrum absorbed is
important. Thus, judging by antibody titres and immunoglobulin levels,
lamb ^08 must have ingested about 1/5 the amount of colostrum received
by its twin (k07), rendering it susceptible to the challenge infection
while its sibling was immune.
The reason for the lack of detectable nasal antibody in these
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lambs after infection with PI is not known. Nasal antibody was
previously detected in colostrum deprived lambs of this age after
infection with virus (Section III, part 2). Possibly the presence
of maternal antibody inhibited active production of nasal antibody.
However the result needs to be confirmed before such speculation can
be substantiated.
Of considerable interest was the finding that high levels of IgG,
greater than adult concentrations in some cases (Section II), were
present in the nasal secretions, with nasal antibody also present in
those lambs which had the highest serum titres. Although no pre-
suckling samples were taken, it is unlikely that the very high IgG
levels in the nasal secretions wex-e due to active production by the
lambs either in utero or early in life. The lambs in this experiment
had been weaned from the ewes and reared on substitute milk containing
no detectable imtaunoglobulin. Thus the source of nasal secretion IgG
was not from milk inhaled into the nasal secretions. It seemed much
more likely that the IgG in the nasal secretions was passively
acquired after transudation from the serum through the newborn lamb's
nasal mucosa. This proposal was substantiated by the finding that
nasal secretion IgG- levels fell as the lambs grew older, paralleling the
situation in the serum. In contrast, the nasal secretions collected
from more than 50 colostrum deprived lambs of similar age (Section III,
part 2) contained very low levels of IgG which gradually increased as
the lambs grew older.
No occult blood was detected in the nasal secretion samples tested.
Nevertheless the possibility existed that the apparent transudation of
IgG from the serum into the secretions was caused by trauma to the
delicate nasal mucosa of the newborn lamb. This possibility was tested
in the next part of this thesis.
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PART 2
Maternal Immunoglobulins and Parainfluenza 3 Virus Inhibitors
in the Serum and Nasal Secretions of Newborn
Lambs.
Introduction
In the first part of this section immunoglobulins and PI antibodies
were found in the nasal secretions of newborn suckled lambs. It seemed
likely that this immunoglobulin was of colostra! origin. However nasal
secretions had not been collected before the lambs sucked. In
addition, the possibility had not been ruled out that the nasal
secretion IgG had transuded from serum following trauma to the delicate
nasal mucosa by the tampons.
The experiment to be described was designed to examine in more
detail the possibility of colostral derived immunoglobulin reaching the
nasal secretions. Samples were collected from a total of 3^ lambs,
which were not inoculated with PI^. Attempts were made to obtain pre-
suckling samples of all the fluids collected. Nasal washings, as well
as nasal secretions obtained by tampons were examined for immuno¬
globulins. In addition naturally reared lambs were compared with lambs
which had ingested colostrum and which were subsequently reared on
immunoglobulin-free milk substitute. This was to ascertain whether
sucking natural milk altered the immunoglobulin content in the lambs'
nasal washings. Samples of lachrymal fluid were obtained from some
lambs to discover whether passively acquired immunoglobulin was
present in this fluid. Changes in the immunoglobulin concentrations
were measured in serial serum samples from the lambs up to 3 weeks of




Ewes and Lambs. Thirty four lambs which were the offspring of 19 ewes
were examined in this experiment. Ten pairs of twins and b single
lambs from lb Suffolk ewes were sampled while sucking their dams. Five
pairs of tv/in lambs from 5 Scottish Blackface ewes were allowed to
suck for one day and then were removed from the ewes and housed indoors.
These lambs v/ere fed milk substitute which contained no detectable
irnmunoglobulin.
Sampling. Colostrum was obtained before suckling. Serum was harvested
from up to 5 ml of blood which was withdrawn from the jugular vein.
Nasal secretions were collected with small pieces of tampon as before
(Section II, part 2). Care was taken to avoid trauma to the nasal
mucosa. Usually 0.1 ml to 0.5 ml of fluid was obtained after the
tampon had been squeezed out in a 1 ml syringe. Nasal washings wore
collected by instilling 5 ml of PBS into each nostril and collecting
the expelled fluid in a universal bottle. Between 3 and 8 ml of fluid
was recovered from each lamb. Each nasal washing sample was
concentrated 10 fold by dialysis against polyethylene glycol (20,000 MW).
Tears were collected as previously described (Section II, pax't 2).
Samples of nasal secretions were tested for occult blood and all
samples of each fluid were stored at -20°C until assayed for immunoglobulin
content.
Scheme of Experiment (Table l6). Pre-suckling samples of each body
fluid were either obtained within half an hour of birth or else the
lambs were removed from their dams at this time and sampled within
three hours. Blood and colostrum samples were obtained from most of
the ewes at this time. Thereafter samples of each fluid were collected

















Blood&nasal Blood&nasal washingsand lachrymalfluid
Natural Artificial
samples were not obtained from the Scottish Blackface lambs (Group C).
Nasal secretions were obtained from 1*+ of the Suffolk lambs (Group A),
whereas nasal washings were collected from the remaining 10 Suffolk
lambs (Group B) and from the Blackface lambs (Group C). Lachrymal
fluid samples were obtained from Group C only.
Results
Mean immunoglobulin concentrations are presented in the text with
their Standard Error.
Ewe sera and colostra. The mean immunoglobulin concentrations in the
ewe sera were: IgG 32.7 + ^.5 IgM 1.72 + O.lh mg/ml and IgA 0.17 +
0.02 mg/ml. In the colostrum the mean concentrations were: IgG 101.2
+ 7.2 mg/ml; IgM 2.9 + 0.2 mg/ml and IgA 6.2 + 0.9 mg/ml (Table 17).
No correlation was observed in serum and colostral immunoglobulin
concentrations of the 12 ewes from which both samples were collected
(Table 18).
Lamb sera. Low levels of IgM were detected in the pre-suckling serum
samples from all the lambs (Table 19). IgA was present in '+ of these
sera, whereas IgG was found in 15 samples. IgA and IgG levels were low,
except for lamb 320, which had a serum IgG concentration of 70 mg/ml.
Maternal immunoglobulins reached peak levels in the lamb sera on
day 1, thereafter declining over the 3 'week period of monitoring.
There was considerable variation in the peak levels in individual
lambs (Table 17). Six of the lambs (Nos. 306, 307, 316, 319, 1680
and l68l) had serum IgG levels less than 20 mg/ml and these animals
were considered hypogammaglobulinaemic. Excluding these 6 lambs, the
mean serum immunoglobulin concentrations on day 1 were: IgG ^7.9 +





Colostrum Lamb No. Serum (day 1)
B5^3
B563
10399 108 2.k §.2
10559 165+ k.l 7-9
10679 96 1.5 5.8
10500 96 1.8 5+.0
10328 78 0.8 6.2
A789 10'4 2.2 2.'4
10675 66 2.2 3-3
1033^ 129 3.2 5-8
10677 93 b.i 1.5
10501 66 3-0 3.3
10555 8k 2.1 6.7
10355 50 3.8 3.3
A775 96 3.2 3.9
10^09 93 3.k 54.6
9781 168 '+.5 17-3
5V26 102 3.6 16.1





301 654.0 3.6 2.0
302 36.5 2.3 0.7
303 5f8.o 3'k 1.3
30'4 954.0 9.6 2.6
305 545.0 1.6 2.3
306 8.8 0.3 0.1
307 0.9 0.2 0
308 75-0 0.8 2.6
309 50.0 0.7 2.6
311 75-0 3.3 1.3
3.2 33-0 0.7 1.1
313 547.0 1.54 0.7
316 8.2 0.5 0
317 21.5 1.7 0.7
'
318 29.5 2.0 0.3
319 11.0 1.1 0
320 5454 . 15 6.8 0.6
321 654.0 3.8 0
3254 549.0 2.2 3.2
325 71.0 5.8 1.3
328 39.15 5.5 1.3
329 62.0 3.0 0.5
330 92.0 5.8 0.9
331 547.0 54.8 1.0
1670 38.0 1.5 5.8
1671 26.0 1.1 3.0
1672 21.0 0.9 l.l
1673 354.0 1.5 3.6
16754 67.0 54.5 3.0
1675 52.0 5.1 1.3
1680 2.5 0.1 0
1681 10.0 0.5 0
1682 27.0 2.1 0.5









IgG IgM IgA IgG IgM IgA
10399 108 2.k 6.2 31 2.3 0.2
10599 l6if k.l 7.9 33 l.if 0.3
10679 96 1.5 5.8 3k 0.9 0.1
10500
A-
96 1.8 if.O k9 1.2 0.1
A.
10328 78 0.8 6.2 68 2.1 0.3
A789 10k 2.2 2.if 39 2.1 0.1
10675 66 2.2 3.3 29.5 2.1 0.2
1033^ 129 3.2 5.8 38 1.6 0.2
10677 93 k.l 1.5 15 2.1 0.1
10501 66 3.0 3.3 13.5 1.9 0.1
10555 8k 2.1 6.7 11 0.9 0.3
B
10355 50 3-8 3-3 NT NT NT
A775 96 3-2 3.9 NT NT NT
10^09 93 3-k if.6 35 1.9 0
NT = Not Tested.
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Table 19
Immunoglobulin Concentrations (mg/ml) in the Precolostral Lamb
Sera





























































































































NT - not tested.
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Three of the 6 hypogammaglobulinemia lambs had siblings with
normal serum immunoglobulin levels; thus considerable variation could
be found in the serum immunoglobulin concentrations of sibling lambs.
Moreover in certain pairs of lambs (Nos. 312 and 313, 320 and 321, 324
and 325> 167^ and 1675), the variation in the levels of one immuno¬
globulin class did not parallel the variation in the other 2 classes
(Table 17). The b single lambs sampled did not have noticeably higher
serum immunoglobulin levels than individual twin larnbs.
From maximum concentrations on day 1, the levels of maternal IgG,
IgM and IgA declined at different rates in the lamb sera. Excluding
the 6 lambs with the low initial levels, the changes in mean serum
immunoglobulin levels over the 3 week period were plotted and
calculation of the regression coefficients revealed the following half
lives: IgG 13.7 days; IgM 'f.l days and IgA 1.8 days (Fig. 39).
Although one ewe (No. 1033'+) had an indurated mammary gland, no
obvious reason was found to account for the remaining 5 hypogamma¬
globulinaemic lambs. One of these lambs died of an undiagnosed cause.
Some of these lambs showed increases in serum IgM and IgG levels,
indicating active synthesis of these immunoglobulins before three
weeks of age.
Nasal secretions. No .IgG was detected in the nasal secretions collected
from newborn lambs prior to sucking but it was present in all samples
obtained on day 1, approximately 2b hours after first sucking. Great
individual variation in the concentrations was noted and there was
considerable variation in samples taken from sibling lambs. Those
lambs with lower serum IgG levels did not have appreciably lower levels
of IgG in their nasal secretions. IgG concentrations reached a peak
on day 1 and thereafter declined (Fig. ^+0).




- standard error of the mean.
 
Fig.kOSerialchangesinthesasecr tionimmunoglobuliconcen rations ofGroupAlambs. —standarderrorofthemean.
 
IgA was not detected in any nasal secretion samples before day 5, when
it was found in one lamb, but IgA was found in the nasal secretions of
most lambs by day 1^+ (Fig. ;+0). IgM appeared in the nasal secretions
about the same time as IgA.
Nasal Washings. Concentrations of immunoglobulins in nasal washings
collected from Groups B and C were approximately twenty-fold less than
those in nasal secretion samples. However, the qualitative changes
observed over the period of monitoring were similar (Fig. ^1). IgG
was not detected in any precolostral samples but was consistently
present (in both Groups B and C) after sucking. IgA and IgM were
detected in nasal washings from most lambs by day 14, and in several
lambs IgA was the predominant immunoglobulin in the nasal washings by
3 weeks of age.
Lachrymal Secretions. The changes in the mean concentrations of immuno¬
globulins in the lachrymal fluid of lambs in Group C are shov/n in Fig.
k2. As in nasal secretions or nasal washings, immunoglobulins were not
detected in precolostral samples, but after sucking IgG was present in
all samples. IgA and IgM were not detected until lambs were 2 to 3
weeks old, but mean IgA levels exceeded mean IgG levels by 21 days
after birth.
PI Inhibitors in Serum and Nasal Secretions. Sera collected from 10
one day old lambs and their dams were titrated for HI antibody to
Within pairs of twin lambs individual serum HI titres and IgG
concentrations correlated closely (Table 20) and relative to serum
IgG levels, the antibody titre of each lamb tended to reflect that of
its mother. However 3 lambs had titres of 10 or less. In 2 cases
(Nos. 306 and 307) this was due to poor transfer of IgG from dams
which had serum antibody. The third lamb (No. 3H) had received a
95
Fig. kl Serial changes in the immunoglobulin concentrations
of the nasal washings collected from Groups B and C.



































































large amount of colostral IgG but its dam had no detectable serum HI
antibody.
Where sufficient sample was available, precolostral and day 1 nasal
secretions from lambs in Group A were tested for HI activity, litres of
up to 8 were detected in all precolostral samples tested, but no rise
was noted on day 1 despite the finding that some lambs had serum titres
of AO. Virus neutralising activity was. not detected in any precolostral
or day 1 samples.
Fractionation of Nasal Secretions. Fractionation by gel filtration of
a pool of nasal secretion samples collected on days 1 to 1*+ from lambs in
Group A showed that HI activity was confined to the protein peak eluted
at the void volume of the column (Fig. ^3)• No IgA or IgM was detected
in these fractions. However, virus neutralising activity was also
demonstrated in this region, and in fractions eluted after the IgG peak.
Fractions containing IgG had no detectable antibody activity. Pooled
concentrated nasal washings from lambs less than one week old were
filtered through the same column. IgG eluted over the same volume as
in Fig. was the only immunoglobulin detected.
Discussion
Precolostral serum concentrations of immunoglobulin varied widely
and, as shown in calves (Penhale et al, 1973)» it is clear that lambs
are not entirely agammaglobulinaemic at birth. Indeed it has been
shown that the ovine foetus is immunologically competent as early as
the 66th day of gestation (Silverstein et al, 1963) and it seems
possible that the relatively high levels of IgG and IgM observed in
certain lambs prior to suckling were the result of an antigenic
stimulus in utero, possibly due to an infectious agent. High serum
immunoglobulin concentrations have been found in lambs born from ewes
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infected with Border Disease agent (C. Gardiner, Personal
Communication). IgM was the most consistently detected and usually
the most abundant immunoglobulin in the precolostral serum samples as
noted by Cole and Morris (1971). However the level of serum IgG was
so high in the first sample collected from one lamb (No. 320) that
the efficiency of surveillance may be questioned and it could be
suggested that this lamb had sucked. There is no evidence that this
was the case and this anomaly remains unexplained.
The great variation in serum immunoglobulin concentrations in
individual lambs after sucking is a reflection on the amount and
quality of colostrum ingested as well as the time at which sucking
first occurred. No relationship was evident between serum immuno¬
globulin levels in day-old lambs and the concentrations in the
colostrum of their dams. Similar findings have been reported by
Harker (Personal Communication) and in cattle by Penhale et al
(1973).
Six of the 3*+ lambs (18%) were considered hypogammaglobulin-
aemic. A similar proportion of lambs were reported to be hypogamma-
globulinaemic in a survey carried out in 72 lambs from Scottish
Blackface ewes on a commercial hill farm, (Reid, 1972), and Harker
(197*0 found 19% of lowland lambs hypogammaglobulinaemic. The dam of
one hypogammaglobulinaemic lamb in the present study had an
indurated mammary gland, but no obvious explanation could be found
for the hypogamrnaglobulinaemia in the other lambs.
Considerable individual variation was found in the serum immuno¬
globulin levels of twin lambs as reflected in the serum titres to
Faye et al (1967) previously reported variation in the PI HI titres
of sibling lambs. This variation in twin lambs may be due to unequal
vigour at birth with the first born having a better chance to ingest
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colostrum. In some cases the variation in IgG and IgA levels in the
sera of twin lambs was not paralleled by the variation in IgM levels.
This may have been d.ue to the time after birth when the colostrum was
first ingested, because it has been reported in calves that absorption
of the different immunoglobulins from the gut stops at different
times: estimated as 27 hours for IgG, 22 hours for IgA and 16 hours
for IgM (Penhale et al, 1973)• Thus,if a similar situation exists in
lambsja twin lamb which for example received a small amount of colostrum
before 16 hours would be expected to have relatively lower serum IgA
and IgG levels but relatively higher IgM levels than its sibling which
absorbed a larger amount of colostrum after 16 hours.
The half life of 13.5 days for maternal IgG is very close to the
value of 13-7 days recently obtained for the decline in lambs' maternal
antibody titres to louping ill virus (Brotherston and Boyce, Personal
Communication) and Nansen and Aalund (1972) recorded half lives of
about 10 days for radiolabelled IgG^ and IgG^ in sheep. In the calf,
colostral IgG appears to decline more slowly than in the lamb, but the
half lives for IgM and IgA are very similar to those estimated here
(Logan et al, 1973; Porter, 1972; Husband et al, 1972).
The finding that IgG was present in the nasal secretions or nasal
washings after suckling shows that colostral IgG passes into the nasal
secretions. Since this occurred in lambs fed immunoglobulin-free
artificial milk, the source of the nasal fluid IgG could not be from
inhalation of natural milk IgG during sucking. IgG was also found in
the lachrymal secretions of newborn lambs after suckling as previously
reported (Sullivan et al, 1969)• Neither IgA nor IgM was detected in
these fluids before the lambs were one week old. Therefore, it seems
that the nasal and conjuctival mucous membranes, are unlike those of
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the gut which are permeable to all immunoglobulins in the first few
hours after birth. Gel filtration analysis showed that the IgG in
nasal secretions or washings was eluted in a similar position to
serum IgG, indicating that the intact immunoglobulin molecule passes
into the nasal mucus. In contrast the urine of newborn suckled
calves contains only Fc and Fab fragments of IgG (Kickhofen et al,
1971).
The mechanisms whereby colostral IgG passes into lachrymal and
nasal secretions are unknown. However, it is well known that IgG^
is selectively transferred from serum into bovine or ovine colostrum
(MacKenzie and Lascelles, 1968). More recently selective transfer of
IgG^ has been noted in ovine saliva and milk and in bovine lachrymal
and other mucous secretions (Watson and Lascelles, 1973 a and b;
Pedersen, 1973; Curtain et al, 1971). This mechanism could account
for the presence of maternal IgG^ in the nasal secretions of newborn
suckled lambs, since the predominant colostral immunoglobulin is
IgG^. The gradual appearance of IgA and IgM in the nasal and
lachrymal secretions is presumably due to local active production of
these immunoglobulins.
The concentration of the immunoglobulins in nasal washings was
much lower than the concentration in nasal secretions collected by
tampons. The use of tampons is a more efficient method of collecting
nasal mucus, as was further shown when IgM and IgA were detected
earlier in Group A nasal secretions. The possibility that the
increased concentration of immunoglobulin in the nasal sec etions was due
to the tampons causing trauma to the mucosa with consequent transudation
of serum immunoglobulins can be excluded since IgA and IgM, which were
oresent in serum, were not found in 1 or 3 ^ay old nasal secretions.
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Mean IgG levels in the nasal secretions of day-old lambs were
about 1/50 of the mean serum levels. Since the highest serum HI titre
in the lambs in this group was ^40, this may account for the fact that
no rise in titre was recorded in the nasal secretions after sucking.
Fractionation confirmed that PI antibody could not be detected in
pooled nasal secretions. However HI activity was found in the
exclusion peak from gel filtration. This activity was presumably
caused by the same inhibitor present in precolostral samples and
previously detected in nasal secretions from specific pathogen free
and conventionally reared lambs (Section III). Since IgM was not
detected in these fractions in this experiment, the activity was
unlikely to have been due to IgM antibody. The first peak of
neutralising activity found in the nasal secretion fractions was
assumed to be caused by the same inhibitor. However the cause of
the neutralising activity eluted after IgG is not known.
McKercher and collaborators (1972) found neutralising activity
to PI in the nasal secretions of 3 month old calves. This activity
was assumed to be due to maternal antibody reaching the nasal secretions.
The situation was not clear however, since neutralising activity was
also found in the nasal secretions of some colostrum deprived calves.
The nasal secretions of calves have also been examined for maternal
antibodies to rinderpest virus (Provost, 1970) and, while no antibody
was found in the nasal secretions of older calves, 2 one month old
calves with serum titres greater than 100 did have nasal secretion
neutralising antibody. Nasal antibody was not detected in a third 1
month old calf without serum antibody. Bernhardt and Bengelsdorff
(1973) found HI activity to PI^ in the nasal secretions of two 8 day
old colostrum fed calves. They attributed this activity to maternal anti¬
body which had passed into the secretions, but presuckling samples were
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not tested and the activity was not shown to be due to immunoglobulin.
Findings in this experiment, together with a report describing HI
activity in colostrum deprived calves nasal secretions(Morein 1972),





Ovine IgA, IgM and IgG and antisera specific for these immuno¬
globulins were prepared in the first part of the experimental work
described in this thesis (Section II, part 1). These reagents were
used to determine the levels of each immunoglobulin in the respiratory
secretions and certain other body fluids of adult sheep. The results
showed that IgA was the major immunoglobulin in saliva and in the
respiratory and lachrymal secretions while IgG was the predominant
immunoglobulin in colostrum, milk, bile and serum. The immunoglobulin
concentrations found in serum, saliva and mammary secretions
approximated values reported by others for the sheep (Pahud and Mach,
1970; Watson and Lascelles, 1973 a and b). No reports for sheep were
available to compare the results obtained for the other fluids
examined, but :.he concentrations of IgA, IgG and IgM found in nasal
secretions, tears and bile were approximately equivalent to those
estimated for the bovine (Mach and Pahud, 1971; Duncan et al, 1972).
Lung fluid from sheep clinically affected with pulmonary adeno¬
matosis was a useful source for preparing IgA since it contained
high concentrations of IgA with a high IgA:IgG ratio. Serum from
such sheep contained the normal high IgG:IgA ratio, showing that
the lung fluid was not a simple transudate from plasma. IgA anti¬
bodies to Mycoplasma ovipneumonia were present in the lung fluid,
however the significance, if any, of these antibodies and the
function of this large amount of IgA remain to be elucidated.
Thus the results from Section II of this thesis established
that an IgA antibody system existed in the ovine respiratory tract.
Mean IgA concentrations were higher in the respiratory secretions
than serum, suggesting that this immunoglobulin was either locally
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produced in the respiratory tract or selectively derived from serum.
However fluorescent studies on other ovine mucous surfaces (Lee and
Lascelles, 1970; Curtain and Anderson, 1971)> and immunochemical
measurements on sheep milk and saliva (Watson and Lascelles, 1973
a and b) suggest local production of IgA and there is no reason to
suspect a different situation in the respiratory tract.
Since IgA antibodies to mycoplasma had been found in lung
fluid, attempts were made to detect locally produced antibody in
the respiratory secretions of k lambs IN inoculated with live PI
virus. The results showed that neutralising antibody was present
in the nasal secretions of 3 lambs 5 days after instillation of
the virus, whereas in the remaining lamb significant titres were
not recorded before day 18. Nasal secretion antibody was usually
detected before either neutralising or HI antibody in the serum, but
did not persist as long as serum antibody, and could not be detected
consistently by 3 to k weeks post inoculation. Marked day to day
variations occurred in the concentrations of IgA, IgG and IgM in
the nasal secretions collected from both infected and control lambs.
Thus it was pot possible to associate the appearance of nasal
antibody with an increase in immunoglobulin levels. However
analysis of nasal and tracheo-bronchial secretion pools by gel
filtration revealed that the bulk of specific anti-viral activity
in the respiratory secretions was associated with IgA. Thus it
was concluded from the experiment that sheep can manufacture locally
produced IgA antibodies after infection with a respiratory virus.
Detection of specific IgA antibodies was complicated by a
non-antibody inhibitor of PI^ also present in these secretions
This inhibitor was not due to a factor present in the tampons used
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to collect the secretions and was later found in newborn and SPF
lamb nasal secretions, devoid of detectable immunoglobulin (Sedtion
III, part 2, Section IV, part 2). It inhibited the HA of PI^, Pl£>
PI-^ and NDV and was only partially sensitive to treatment with RDE.
This substance mainly inhibited HA but when concentrated also
neutralised PI^. Similarly Gates et al (1970) recorded non-specific
neutralisation of PI^ with concentrated nasal washings from calves.
However pre-inoculation nasal secretions and secretions from
control Iambs did not neutralise the virus and so this test was
used to detect antibody in unfractionated secretions.
Sheep saliva contains a well characterised large molecular
weight glycoprotein, which is excluded from G200 Sephadex and which
inhibits the HA of influenza virus (Bhargava et al, 1966; Gottschalk
et al, 1972). The inhibitor found here in ovine nasal secretions
was estimated by gel filtration to have a molecular weight of about
10 and may be a similar substance.
It is of interest to compare the findings in this sheep
experiment with reports of PI^ specific IgA antibodies in bovine
nasal secretions. Fractionation of bovine nasal washings using G200
Sephadex has revealed a major exclusion peak which contains IgA
(Morein, 1970; Duncan, et al, 1972). Morein (1970) found PI HI
activity in nasal washings from naturally infected cattle and, after
fractionation of these washings using Sephadex G200, he concluded
that the nasal wash HI activity was due to specific IgA antibody.
Morein, (1970) also reported that the PI HI titre of the nasal
washings was proportional to the protein content of the sample,
a finding which implied that any increase in the HI titre would
be paralleled by higher levels of IgA. Gel filtration of nasal
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secretions of lambs in this study was carried out on Biogel A 1.5 m
which gives greater separation of IgM, IgA and IgG than Sephadex
G200 (Section III, Materials and Methods). Results indicated
that the PI-j HI activity in the respiratory tract secretions of
lambs was mainly due to a non-immunoglobulin protein which was
eluted before IgA and which was the major protein in the secretions,
as estimated by absorption at 25^ nm (Sections III and IV).
Furthermore after infection of these conventionally reared lambs
and the SPF lambs (Section III, part 2), no rise in nasal secretion
IgA levels were found.
These results suggest that certain reported findings of IgA
antibodies with PI^ HI activity in bovine nasal washings may have
been due, in part, to non-immunoglobulin inhibitors (Morein, 1970;
Mesnik et al, 1971). Indeed, Morein (1972) later reported that
the nasal secretions of day-old colostrum deprived calves inhibited
the HA of NDV, PI and PI^ viruses. He detected IgA in these nasal
secretions and implied that the HI activity might be due to this
'early IgA' functioning as a non-specific inhibitor as suggested
by Alford at al (1967). No IgA was detected in any of the newborn
lambs' nasal secretions examined in this thesis (Section IV, part 2).
It is not clear whether Morein ruled out the possibility that his
anti-IgA serum reacted with free secretory component, which may
have been present in the nasal secretions of the newborn calves.
Free secretory component, without detectable IgA, has been found in
the saliva of newborn calves (Mach and Pahud, 1971).
After parenteral or IN vaccination of calves Morein (1972)
found increased nasal secretion HI titres to PI^ and PI^ viruses
but not to NDV. He thought this might reflect a partial antigenic
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relationship between the parainfluenza viruses or a broader
specificity of IgA as suggested by Waldman et al (1970a). In
contrast, no PI^> or activity ascribed to IgA activity
was found in the nasal secretions of the lambs which were inoculated
with PI^ in the present study (Section III, part 1).
However more recently, IgA has been prepared from calf nasal
secretions by ion exchange and gel filtration chromatography, and
only IgA molecules from calves which had been infected with PI
were shown to attach to PI^ virions as visualised by electron
microscopy (Morein et al, 1973). In accord with findings in calves,
no PI specific IgG antibody was found in ovine nasal secretions
after IN infection with virus (Morein, 1972).
It was considered that the IgA antibody system in the respiratory
secretions might be an important defence mechanism in preventing
respiratory infections of sheep. Attempts were therefore made to
define the role of nasal secretion antibody to PI with vaccination-
challenge experiments in SPF lambs. For convenience of sampling,
nasal secretions were chosen as a model respiratory secretion. SPF
lambs were used so that orevious or intercurrent infections with PI7
3
could be excluded. It was thought that changes in serum and nasal
secretion immunoglobulin levels would be more evident in SPF rather
than colostrum deprived conventionally reared lambs which would be
exposed to many more antigens. In addition young SPF lambs were
considered likely to be clinically susceptible to challenge with PI^>
since respiratory tract lesions had previously been produced in new¬
born lambs (Hore and Stevenson, 1967). Challenge virus was
administered by aerosol because this was considered the likely route,
of natural infection. Furthermore clinical disease had been
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produced in calves experimentally challenged with aerosols of PI^
(Frank and Marshall, 1971).
However a complete absence of clinical disease was found when
these lambs were exposed to PI either IN, IM or by aerosol (Section
III, part 2). Thus virus exdretion from the nose was used as an
index of challenge immunity. Previously this method had been
employed in calves (Gates et al, 1970; McKercher et al, 1972) and
Gilmour et al, (1968) showed that the technique could be applied to
PI^ in sheep. Using this criterion for measuring protection, a
preliminary dose of live virus given either IN or IM protected the
lambs against subsequent aerosol challenge. Live virus administered
by either route stimulated similar serum antibody titres, but nasal
secretion antibody was only observed after IN inoculation. However,
although no virus was recovered after challenge from lambs vaccinated
by either method, no post challenge changes in nasal antibody were
found in the IN group indicating that they were resistant, whereas a
marked increase in titre occurred in the IM vaccinated group and in
the other vaccinated groups which shed virus after challenge. Possibly
the group IM vaccinated with live virus had a low grade post-challenge
infection, which stimulated a nasal antibody response but was undetected
by the virus isolation technique.
McKercher et al, (1972) reported equivalent post-challenge nasal
antibody changes in colostrum deprived calves vaccinated IM or IN
with a living attenuated PI vaccine. Others have demonstrated in
calves that nasal secretion antibody was better stimulated by IN
vaccination of live virus (Marshall and Frank, 1971; Morein, 1972).
and have shown that this route is more protective than IM inoculation
(Gates et al, 1970; Gutekunst et al, 1969; Frank and Marshall, 1971).
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No protection and no antibody was observed in lambs vaccinated
either once or on 2 occasions with inactivated virus IN. Poor
antibody responses have also been reported in calves vaccinated with
inactivated PI by the respiratory route (Marshall and Frank, 1971;
Morein et al, 1973)•
IM vaccination with inactivated virus alone elicited low serum
titres only and was not protective. However emulsification with FCA
rendered the inactivated virus highly immunogenic, stimulating high
serum and nasal antibody titres, which increased to very high levels
after subsequent vaccination, either IM with FCA, or IN without
adjuvant (Section III, experiment 2). Nasal secretion antibody titres
were greater, albeit temporarily, when the second vaccination was
given IN. However both vaccination methods conferred protection against
infection since virus was not recovered from either group of lambs
after challenge.
There was some evidence that the presence of high circulating
immunoglobulin levels prior to parenteral vaccination might reduce
the resulting nasal secretion antibody titre (Section III, experiment 3)•
However Gilmour et al (1968) found that 2 subcutaneous injections of
inactivated PI^ in incomplete Freund's adjuvant stimulated serum
antibody in young adult sheep and conferred protection against
challenge infection. However nasal secretion antibody was not assayed
in that investigation.
After the SPF lambs were exposed by aerosol to PI^, increased
concentrations of IgM were associated with the primary serum
antibody response and increased concentrations of IgG with the
secondary response. However no changes in nasal secretion immuno¬
globulin concentrations were associated with nasal antibody after
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infection with the virus, although all 3 immunoglobulins were -present
in the secretions. Morein (1972) found IgA, IgG and IgM in the nasal
secretions of young colostrum deprived calves which had been
infected with but since he did not examine control animals, it
was not clear whether these immunoglobulins were produced in response to
the infection.
Some evidence was found for an anamnestic nasal antibody
response in the lambs, in the first experiment in Section III. Thus,
with the exception of the IN vaccinated lambs which v/ere considered
solidly immune, nasal antibody appeared more quickly in all vaccinated
groups after challenge com-ared with the unvaccinated control lambs.
Unfortunately it was not possible to determine which immunoglobulins
were involved in this response. Evidence for the existence of an
anamnestic IgA antibody response in man and laboratory animals is
conflicting (Ogra and Karzon, 1969 a; Buscho et al, 1972; Gerbrandy
and van Dura, 1972), but data clearly demonstrating an anamnestic
nasal antibody response to PI^ has been presented for the bovine,
although it was not shown whether this response was IgA mediated
(Marshall and Frank, 1971; Woods et al, 1973)*
Following vaccination of the lambs with inactivated virus in
FCA, high levels of antibody and IgG were observed in the nasal
secretions and serum (Section III, experiment 2). Fractionation
by gel filtration and immunoelectrophoresis confirmed that the bulk
of serum antibody was associated with IgG (igG^ and IgG2), whereas
the nasal secretion antibody was IgG^ only. This was an interesting
contrast to the earlier finding that IgA antibodies were produced
following IN instillation of live virus (Section III, part 1). It
is suggested that the effect of FCA was to stimulate high levels of
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circulating IgG^ and IgG^ antibodies and that the IgG^ subclass was
selectively transferred into the nasal secretions. This proposal
is-likely in view of the recent evidence accumulating from immuno¬
chemical and radiolabelling studies with IgG^ and IgGy showing that
IgG^ is selectively transferred into a number of sheep and cattle
body fluids including respiratory, lachrymal, lacteal, cervico-
vaginal and salivary gland secretions (Curtain et al. 1971; Duncan
et al, 1972; Pederson, 1973; Watson and Lascelles, 1973 a and b).
These experiments were not conducted with regard to micro-organisms
and specific antibody titres were not measured. However 2 recently
reported studies with cattle show equivalent results to the findings
made in the present investigation with the lambs and PI . Garland
(197*0 reported that antibodies dn the nasal secretions of cattle
recovered from foot and mouth disease were of the IgA type, but,
after subcutaneous immunisation with inactivated foot and mouth
disease vaccine, the secretion antibodies were largely IgG.
Similarly Corbeil et al (197*+) found IgA antibodies in the cervico-
vaginal mucus of heifers locally infected with Vibrio foetus,
whereas cattle parenterally immunised with killed organisms in
FCA had IgG antibodies in the vaginal mucus. In contrast Morein
(1972) associated the HI activity in the nasal secretions of
parenterally immunised calves with IgA - antibody. For reasons already
mentioned, this apparent discrepancy of results might be explained if
some of the HI activity Morein was measuring was due to non-antibody
inhibitors. Others have detected low levels of neutralising
antibody in the nasal secretions of older calves, parenterally
immunised with Ply but the immunoglobulin type or source of
this antibody was not determined (Marshall and Frank, 1971;
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McKercher et_al, 1972).
No delayed-type skin hypersensitivity reaction was seen in
larrfbs experimentally infected with PI^, but the results were not
conclusive (Section III, part 1). Positive intradermal tests have
\
been demonstrated in cattle naturally infected with PI (Morein
3
and Moreno-Lopez, 1973) an^ systemic delayed hypersensitivity has
been reported in guinea pigs IN infected with this virus (Wetherbee,
1973)• Cell mediated immunity to influenza virus has been
detected in alveolar lymphocytes from humans and guinea pigs
(Jurgensen et al, 1973; Waldraan et al, 1972; Gadol et al, 197*0,
and it seems likely that this type of immunity may also play a role
in preventing infection of the respiratory tract.
In the vaccination-challenge experiments with the SPF lambs
high antibody titres correlated with protection against infection
with but it was not clear whether antibody was in fact
responsible for the protection conferred, because cellular immune
mechanisms were not monitored. This question was resolved by
challenging very young colostrum fed lambs, which were unlikely to
have been infected with PI and so would lack active immunity to the
5
^ ~ <oi°0
virus. PI7 was recovered on significantly fewer occasions from 3
3 A
lambs with high levels of maternal antibody, compared with 5 lambs
v/ith low levels of antibody. Thus, although the number of animals
involved was small, this experiment indicated that antibody alone
could prevent lambs becoming infected with this virus.
Prechallenge samples of nasal secretions from these lambs
contained IgG and samples from 2 lambs also contained significant
titres of neutralising antibody. It seemed likely that this immuno¬
globulin was of maternal origin and might constitute an important
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defence mechanism in newborn lambs. A more detailed investigation was
therefore carried out involving J>k lambs - the offspring of 19 ewes
(Section IV, part 2). The results confirmed that colostral IgG did
pass into the nasal secretions of these lambs. Precolostral samples
were devoid of immunoglobulin, whereas after sucking IgG only v/as
detected in nasal secretions, nasal washings and tears. Maternal
IgG was also present in these fluids if lambs were removed from
their dams after 2k hours and subsequently reared on immunoglobulin-
free milk substitute. This proved that the IgG present in these
fluids was not derived from milk inhaled during suckling. Since
IgG was present in the nasal washings as well as nasal secretions,
possible trauma, resulting from the use of tampons, was ruled out as
the cause of transudation.
IgG concentrations in the nasal secretions were about 1/50 of
serum concentrations and declined as the lambs grew older in contrast
to the situation in the colostrum deprived SPF lambs (Section III,
part 2). IgA and IgM were first detected in the secretions about
10 days after birth, presumably as a result of local antibody synthesis.
Sullivan et al (1969) reported transfer of colostral IgG into the
tears of newborn lambs, but these authors did not have specific
anti-IgA and anti-IgM sera and could not determine whether the newborn
conjunctiva was selectively oermeable to IgG or was permeable to all
immunoglobulins, like the gut. The finding of colostral IgG (which
is mainly IgG^) in the nasal secretions supported the earlier
suggestion that the IgG^ antibody found in the adjuvant vaccinated
lambs' nasal secretions was selectively derived from plasma.
Serum immunoglobulin levels were also monitored in the lambs
sampled in this experiment. Pre-suckling samples confirmed
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other findings that lambs are not completely agammaglobulinaemic
at birth (Gardiner, Personal Communication). In most lambs large
increases in serum immunoglobulin concentrations were recorded
after birth, but almost 20 percent remained hypogammaglobulinaemic
- a proportion similar to that found in two other recently reported
surveys (Reid, 1972; Harker, 197^). Hypogammaglobulinaemia was
presumably caused by poor ingestion of colostrum, but, with one
exception, the reasons for this were obscure. This relatively high
incidence of hypogammaglobulinaemia is likely to be a major cause
of loss in young lambs as a result of infectious disease. Increased
susceptibility to infection was well illustrated in Section IV, part
f\itSSL5l* cL CalastftX
where one lamb ingested about 1/5 the amount of --00100!rum received
by its twin rendering it susceptible to challenge infection with
PI whereas its sibling remained immune.
Colostral immunoglobulins reached peak levels in the lambs'
sera approximately 2h hours after first suckling. IgA and IgM
declined relatively quickly with mean half lives of 1.8 and 4.1
days respectively. Comparable results have been recorded for the
rate of decline of bovine colostral IgA and IgM in calves' sera
(Logan et al, 1975; Porter, 1972; Husband et al, 1972). However
the results indicated that colostral IgG declines more rapidly in
the lamb than in the calf, since a mean half life value of 13«7 days
was obtained, compared with a figure of 21 days reported for calves
(Logan et al, 1973).
The ewes and lambs sampled in this experiment had low serum
titres to Ply Therefore, since peak maternal IgG levels in the
nasal secretions were approximately 1/50 of the serum concentration,
maternal antibody to PI was not detected in the nasal secretions.
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Presumably antibody was present at undetectable levels in the nasal
secretions, especially since antibody was detected in secretion
samples collected from 2 lambs with high serum titres in the previous
experiment, (Section IV, part l). Low levels of maternal antibody
specific for other respiratory micro-organisms were probably also
present in the nasal secretions of the newborn lambs. These may
play a valuable role in providing transient protection against
respiratory tract infections, before active production of local IgA
and IgM begins at about 2 weeks of age (Sections III and IV). The
same situation might apply to other mucous surfaces including the
conjunctiva.
The protective role of nasal secretion antibody per se is difficult
to evaluate from the results in this thesis. All lambs which had
nasal antibody and were immune to PI also had serum antibody.
However IN vaccination with live virus stimulated higher nasal
secretion titres than live virus administered IM and the IN
vaccinated lambs were considered more resistant to challenge, despite
similar pre-challenge serum titres in both groups. On the other hand
some lambs with serum antibody and without detectable nasal antibody
were also immune to challenge infection (Section IV).
Protection against parainfluenza virus infections in man and
cattle has been found to correlate more closely with antibody
titres in the nasal secretions (Smith et al, 1966; Frank and
Marshall, 1971). Therefore it is reasonable to assume that antibody
in ovine nasal secretions plays some role in oreventing infection
with this virus and possibly with other micro-organisms which
replicate in the respiratory tract. It seems that antibody in
115
lambs' nasal secretions can be stimulated in 2 ways: either, 1) by
IN administration of live virus or, 2) by parenteral immunisation
with inactivated virus in adjuvant. The first method stimulates IgA
antibody which is probably locally produced. The second method results
in IgG^ antibody reaching the nasal secretions, probably by selective
transport from serum. The finding of colostral IgG (which is mainly IgG^)
in newborn suckled lambs' nasal secretions supports this last
suggestion. Other recent evidence is available which suggests that
cattle have these 2 mucous antibody systems (Garland, 197*+; Corbeil
et al, 197*0.
IgA and IgG from bovine cervico-vaginal mucus have been shown
in vitro to have different functional properties with respect to
Vibrio foetus organisms (Corbeil et al, 197*+), but it is not known
if IgA and IgG^ anti-viral antibodies have similar in vivo
properties in the nasal secretions of lambs. In terms of highest neutral¬
ising antibody titres stimulated, IM vaccine with FCA followed by an
IN 'booster' was the best vaccine combination. However it remains to
be seen if this method will be of value in conventionally reared lambs,
particularly since high levels of serum IgG seemed to inhibit the
amount of antibody reaching the nasal secretions (Section III,
experiment 3) • If a practical vaccine of this type were to be
developed then obviously an adjuvant less noxious than comolete Freunds'
would have to be found. Trials would have to be run to ensure that
the anaphylaxis found in this study would not occur following natural
infection with PI .
An alternative vaccination method would be to use live attenuated
virus administered IN. Maternal antibody is less likely to interfere
with this type of vaccination, particularly if vaccination is delayed
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until the lambs are over one month old. By this time maternal antibody
should have disappeared from the nasal secretions and the respiratory
IgA system should be immunocompetent. However more work is necessary
to elucidate the duration of the IgA nasal antibody response and more
direct evidence is required to prove that sheep are capable of an
anamnestic respiratory IgA response.
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List of Abbreviations Used.
DEAE - diethylarainoethyl
FCA - Freund's complete adjuvant
HA - haemagglutination, haemagglutinin
HI - haemagglutination inhibition
IEP - immunoelectrophoresis
IM - intramuscular (ly)
IN - intranasal (ly)
NDV - Newcastle disease virus
PBS - phosphate buffered saline
PI^ - parainfluenza one
PI2 - parainfluenza two
PI^ - parainfluenza three
RDE - receptor destroying enzyme
SAS - saturated ammonium sulphate
SPP - specific pathogen free
TCID<_q - tissue culture infective dose fifty
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'Appendix 1.
Preparation of the buffers used in DEAE cellulose chromatography
0.2M stock solutions of Na I^PO^. H^O and NaH PO^ were made up.
1
0.2M phosphate buffer (PO^) was then prepared by adding the
dihydrogen salt to the disodium salt until the pH fell to 7.6.
Thus 0.01M PO^ was obtained by diluting 0.2M PO^ 1:20 with
distilled water.
A stock solution of 0.2M NaCl was made up and thus 200 ml of e.g
0.01M PO^, 0.01M NaCl (buffer step l) was prepared by adding 10 ml of
0.2M (PO^) to 10 ml 0.2M NaCl and making up to 200 ml with distilled
wat er.
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